☰

Inder M. Verma, PhD - Publications

Affiliations: 
Genetics Salk Institute for Biological Studies, La Jolla, CA, United States 
Area:
genetics and gene therapy
Website:
http://www.salk.edu/faculty/faculty_details.php?id=54
Tree Info Similar researchers PubMed Report error

271/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hara T, Chanoch-Myers R, Mathewson ND, Myskiw C, Atta L, Bussema L, Eichhorn SW, Greenwald AC, Kinker GS, Rodman C, Gonzalez Castro LN, Wakimoto H, Rozenblatt-Rosen O, Zhuang X, Fan J, ... ... Verma IM, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell. PMID 34087162 DOI: 10.1016/j.ccell.2021.05.002  0.421
2019 Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, ... ... Verma IM, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. PMID 31327527 DOI: 10.1016/J.Cell.2019.06.024  0.472
2019 Hara T, Verma IM. Modeling Gliomas Using Two Recombinases. Cancer Research. PMID 31315836 DOI: 10.1158/0008-5472.Can-19-0717  0.344
2019 Masnadi-Shirazi M, Maurya MR, Pao G, Ke E, Verma IM, Subramaniam S. Time varying causal network reconstruction of a mouse cell cycle. Bmc Bioinformatics. 20: 294. PMID 31142274 DOI: 10.1186/S12859-019-2895-1  0.749
2019 Verma S, Yeddula N, Soda Y, Zhu Q, Pao G, Moresco J, Diedrich JK, Hong A, Plouffe S, Moroishi T, Guan KL, Verma IM. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling. Proceedings of the National Academy of Sciences of the United States of America. PMID 30918126 DOI: 10.1073/Pnas.1822155116  0.78
2018 Verma S, De Jesus P, Chanda SK, Verma IM. SNW1 as a novel transcriptional regulator of the NF-κB pathway. Molecular and Cellular Biology. PMID 30397075 DOI: 10.1128/Mcb.00415-18  0.357
2018 Zhu Q, Hoong N, Aslanian A, Hara T, Benner C, Heinz S, Miga KH, Ke E, Verma S, Soroczynski J, Yates JR, Hunter T, Verma IM. Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer. Molecular Cell. PMID 29861157 DOI: 10.1016/J.Molcel.2018.04.023  0.484
2018 Ramaswamy S, Tonnu N, Menon T, Lewis BM, Green KT, Wampler D, Monahan PE, Verma IM. Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX. Cell Reports. 23: 1565-1580. PMID 29719266 DOI: 10.1016/J.Celrep.2018.03.121  0.33
2018 Ogawa J, Pao GM, Shokhirev MN, Verma IM. Glioblastoma Model Using Human Cerebral Organoids. Cell Reports. 23: 1220-1229. PMID 29694897 DOI: 10.1016/J.Celrep.2018.03.105  0.784
2018 Xia Y, Zhan C, Feng M, Leblanc M, Ke E, Yeddula N, Verma IM. Targeting CREB pathway suppresses Small Cell lung Cancer. Molecular Cancer Research : McR. PMID 29523765 DOI: 10.1158/1541-7786.Mcr-17-0576  0.8
2018 Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z. EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis. Molecular Cell. 69: 347. PMID 29351852 DOI: 10.1016/J.Molcel.2017.12.034  0.315
2018 Sulli G, Rommel A, Wang X, Kolar MJ, Puca F, Saghatelian A, Plikus MV, Verma IM, Panda S. Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence. Nature. PMID 29320480 DOI: 10.1038/Nature25170  0.334
2018 Sulli G, Rommel A, Wang X, Kolar MJ, Puca F, Saghatelian A, Plikus MV, Verma IM, Panda S. Abstract 5464: Pharmacologic activation of REV-ERBs is lethal in cancer and oncogene-induced senescence Cancer Research. 78: 5464-5464. DOI: 10.1158/1538-7445.Am2018-5464  0.342
2017 Thanasupawat T, Natarajan S, Rommel A, Glogowska A, Bergen H, Krcek J, Pitz M, Beiko J, Krawitz S, Verma IM, Ghavami S, Klonisch T, Hombach-Klonisch S. Dovitinib enhances temozolomide efficacy in glioblastoma cells. Molecular Oncology. PMID 28500786 DOI: 10.1002/1878-0261.12076  0.33
2017 Ramaswamy S, Tonnu N, Tachikawa K, Limphong P, Vega JB, Karmali PP, Chivukula P, Verma IM. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 28202722 DOI: 10.1073/Pnas.1619653114  0.304
2016 Naldini L, Trono D, Verma IM. Lentiviral vectors, two decades later. Science (New York, N.Y.). 353: 1101-2. PMID 27609877 DOI: 10.1126/Science.Aah6192  0.534
2016 Sancho-Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, Ma L, Morey R, Krause MN, Zembrzycki A, Ansorge O, Vazquez-Ferrer E, Dubova I, Reddy P, Lam D, ... ... Verma IM, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nature Communications. 7: 10743. PMID 26899176 DOI: 10.1038/Ncomms10743  0.322
2016 Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma IM. Targeting NF-κB in glioblastoma: A therapeutic approach. Science Advances. 2: e1501292. PMID 26824076 DOI: 10.1126/Sciadv.1501292  0.357
2015 Yeddula N, Xia Y, Ke E, Beumer J, Verma IM. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 26542681 DOI: 10.1073/Pnas.1520110112  0.804
2015 Friedmann-Morvinski D, Bhargava V, Gupta S, Verma IM, Subramaniam S. Identification of therapeutic targets for glioblastoma by network analysis. Oncogene. PMID 25961929 DOI: 10.1038/Onc.2015.119  0.357
2015 Wickersham IR, Sullivan HA, Pao GM, Hamanaka H, Goosens KA, Verma IM, Seung HS. Lentiviral vectors for retrograde delivery of recombinases and transactivators. Cold Spring Harbor Protocols. 2015: 368-74. PMID 25834255 DOI: 10.1101/Pdb.Prot075879  0.77
2015 Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM. Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nature Cell Biology. 17: 532. PMID 25812528 DOI: 10.1038/Ncb3145  0.772
2015 Menon T, Firth AL, Scripture-Adams DD, Galic Z, Qualls SJ, Gilmore WB, Ke E, Singer O, Anderson LS, Bornzin AR, Alexander IE, Zack JA, Verma IM. Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell. 16: 367-72. PMID 25772073 DOI: 10.1016/J.Stem.2015.02.005  0.338
2015 Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma IM. Abstract A19: Role of NF-κB and gene targets of NF-κB in glioma cell plasticity Brain. 75. DOI: 10.1158/1538-7445.Brain15-A19  0.398
2014 Xia Y, Liu YL, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma IM. A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin. Science Translational Medicine. 6: 263ra161. PMID 25411474 DOI: 10.1126/Scitranslmed.3010382  0.79
2014 Verma IM. Editorial expression of concern: Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proceedings of the National Academy of Sciences of the United States of America. 111: 13241. PMID 25197091 DOI: 10.1073/Pnas.1415649111  0.304
2014 Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunology Research. 2: 823-30. PMID 25187272 DOI: 10.1158/2326-6066.Cir-14-0112  0.368
2014 Spencer B, Verma I, Desplats P, Morvinski D, Rockenstein E, Adame A, Masliah E. A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis. The Journal of Biological Chemistry. 289: 17917-31. PMID 24825898 DOI: 10.1074/Jbc.M114.557439  0.303
2014 Firth AL, Dargitz CT, Qualls SJ, Menon T, Wright R, Singer O, Gage FH, Khanna A, Verma IM. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 111: E1723-30. PMID 24706852 DOI: 10.1073/Pnas.1403470111  0.342
2014 Pao GM, Zhu Q, Perez-Garcia CG, Chou SJ, Suh H, Gage FH, O'Leary DD, Verma IM. Role of BRCA1 in brain development. Proceedings of the National Academy of Sciences of the United States of America. 111: E1240-8. PMID 24639535 DOI: 10.1073/Pnas.1400783111  0.782
2014 Yeddula N, Xia Y, Verma I. Abstract 70: Mouse models of human lung adenocarcinoma: Identification of potential tumor suppressors by functionalin vivoshRNA screening Cancer Research. 74: 70-70. DOI: 10.1158/1538-7445.Am2014-70  0.792
2014 Myskiw C, Kadri S, Ke E, Shishkin A, Friedmann-Morvinski D, Soda Y, Guttman M, Verma I. Abstract 524: Analysis of long non-coding RNA expression and function in a mouse model of glioblastoma Cancer Research. 74: 524-524. DOI: 10.1158/1538-7445.Am2014-524  0.34
2014 Xia Y, Yeddula N, Ke E, Leblanc M, Verma I. Abstract 2973: Mouse models of lung cancer mediated by lentiviral gene delivery Cancer Research. 74: 2973-2973. DOI: 10.1158/1538-7445.Am2014-2973  0.791
2014 Friedmann-Morvinski D, Bhargava V, Gupta S, Verma IM, Subramaniam S. Abstract 1914: Functional characterization of oncogenic-induced dedifferentiation in neurons and astrocytes using DP-seq Cancer Research. 74: 1914-1914. DOI: 10.1158/1538-7445.Am2014-1914  0.334
2013 Verma IM. Medicine. Gene therapy that works. Science (New York, N.Y.). 341: 853-5. PMID 23970689 DOI: 10.1126/Science.1242551  0.335
2013 Polley S, Huang DB, Hauenstein AV, Fusco AJ, Zhong X, Vu D, Schröfelbauer B, Kim Y, Hoffmann A, Verma IM, Ghosh G, Huxford T. A structural basis for IκB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation. Plos Biology. 11: e1001581. PMID 23776406 DOI: 10.1371/Journal.Pbio.1001581  0.486
2013 Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman E, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. The Journal of Clinical Investigation. 123: 405-17. PMID 23241957 DOI: 10.1172/Jci63811  0.342
2013 Krona CC, Boubaker J, Friedmann-Morvinski D, Wong A, McAlonis-Downes M, Koller E, Kim AS, Hung G, Rigo F, Chun S, Vitre B, Bennett F, Verma I, Cleveland DW. Abstract 3302: Antisense oligonucleotide depletion of the mitotic kinesin Eg5 by direct delivery to the brain could be a useful strategy for treating glioma tumors. Cancer Research. 73: 3302-3302. DOI: 10.1158/1538-7445.Am2013-3302  0.339
2012 Holland AJ, Fachinetti D, Zhu Q, Bauer M, Verma IM, Nigg EA, Cleveland DW. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle. Genes & Development. 26: 2684-9. PMID 23249732 DOI: 10.1101/Gad.207027.112  0.302
2012 Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. Molecular Cell. 48: 771-84. PMID 23123196 DOI: 10.1016/J.Molcel.2012.09.028  0.345
2012 Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma IM. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proceedings of the National Academy of Sciences of the United States of America. 109: 12662-7. PMID 22778400 DOI: 10.1073/Pnas.1209965109  0.325
2012 Holland AJ, Fachinetti D, Da Cruz S, Zhu Q, Vitre B, Lince-Faria M, Chen D, Parish N, Verma IM, Bettencourt-Dias M, Cleveland DW. Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis. Molecular Biology of the Cell. 23: 1838-45. PMID 22456511 DOI: 10.1091/Mbc.E11-12-1043  0.306
2012 Liu F, Xia Y, Parker AS, Verma IM. IKK biology. Immunological Reviews. 246: 239-53. PMID 22435559 DOI: 10.1111/J.1600-065X.2012.01107.X  0.767
2012 Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM. Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nature Cell Biology. 14: 257-65. PMID 22327365 DOI: 10.1038/Ncb2428  0.792
2012 Verma IM, Soda Y, Friedmann-Morvinski D, Pastorino S, Kesari S. Abstract SY41-01: Tumor-endothelial transdifferentiation Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Sy41-01  0.302
2012 Friedmann-Morvinski D, Bushong E, Ke E, Singer O, Marumoto T, Soda Y, Ellisman MH, Verma IM. Abstract LB-191: Glioblastomas can originate from neurons in the CNS Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-191  0.348
2012 Xia Y, Yeddula N, Leblanc M, Shaw R, Verma I. Abstract PR3: NSCLC and SCLC mouse models mediated by lentiviral gene delivery Clinical Cancer Research. 18: PR3-PR3. DOI: 10.1158/1078-0432.12Aacriaslc-Pr3  0.803
2011 Suzuki K, Murphy SH, Xia Y, Yokota M, Nakagomi D, Liu F, Verma IM, Nakajima H. Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation. Plos One. 6: e25412. PMID 21966524 DOI: 10.1371/Journal.Pone.0025412  0.732
2011 Hurtado de Mendoza T, Perez-Garcia CG, Kroll TT, Hoong NH, O'Leary DD, Verma IM. Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 17189-94. PMID 21957071 DOI: 10.1073/Pnas.1114226108  0.309
2011 Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ, Orth AP, Chanda SK, Evans RM, Verma IM. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 108: 17117-22. PMID 21949408 DOI: 10.1073/Pnas.1114420108  0.739
2011 Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma IM. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature. 477: 179-84. PMID 21901007 DOI: 10.1038/Nature10371  0.782
2011 Woods NB, Parker AS, Moraghebi R, Lutz MK, Firth AL, Brennand KJ, Berggren WT, Raya A, Izpisúa Belmonte JC, Gage FH, Verma IM. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells (Dayton, Ohio). 29: 1158-64. PMID 21544903 DOI: 10.1002/Stem.657  0.758
2011 Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, Rockenstein E, Verma IM, Masliah E. Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease. Plos One. 6: e16575. PMID 21304989 DOI: 10.1371/Journal.Pone.0016575  0.629
2011 Ruiz S, Panopoulos AD, Herrerías A, Bissig KD, Lutz M, Berggren WT, Verma IM, Izpisua Belmonte JC. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Current Biology : Cb. 21: 45-52. PMID 21167714 DOI: 10.1016/J.Cub.2010.11.049  0.308
2011 Friedmann-Morvinski D, Bushong E, Singer O, Marumoto T, Soda Y, Ellisman MH, Verma IM. Abstract 975: Glioma cell of origin: Reprogramming and cancer stem cells Cancer Research. 71: 975-975. DOI: 10.1158/1538-7445.Am2011-975  0.36
2010 Kivelä AM, Mäkinen PI, Jyrkkänen HK, Mella-Aho E, Xia Y, Kansanen E, Leinonen H, Verma IM, Ylä-Herttuala S, Levonen AL. Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells. Atherosclerosis. 213: 122-8. PMID 20688330 DOI: 10.1016/J.Atherosclerosis.2010.07.015  0.324
2010 Teo H, Ghosh S, Luesch H, Ghosh A, Wong ET, Malik N, Orth A, de Jesus P, Perry AS, Oliver JD, Tran NL, Speiser LJ, Wong M, Saez E, Schultz P, ... ... Verma IM, et al. Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nature Cell Biology. 12: 758-67. PMID 20622870 DOI: 10.1038/Ncb2080  0.357
2010 Agemy L, Morvinski DF, Kotamraju VR, Sugahara KN, Verma IM, Ruoslahti E. Abstract 3703: Nanoparticle-induced targeted pro-apoptotic peptide in glioblastoma Cancer Research. 70: 3703-3703. DOI: 10.1158/1538-7445.Am10-3703  0.302
2009 You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, Tonnu N, Verma IM, Berns MW, Hunter T. CtIP links DNA double-strand break sensing to resection. Molecular Cell. 36: 954-69. PMID 20064462 DOI: 10.1016/J.Molcel.2009.12.002  0.453
2009 Smith JJ, Putta S, Zhu W, Pao GM, Verma IM, Hunter T, Bryant SV, Gardiner DM, Harkins TT, Voss SR. Genic regions of a large salamander genome contain long introns and novel genes. Bmc Genomics. 10: 19. PMID 19144141 DOI: 10.1186/1471-2164-10-19  0.778
2009 Monaghan JR, Epp LG, Putta S, Page RB, Walker JA, Beachy CK, Zhu W, Pao GM, Verma IM, Hunter T, Bryant SV, Gardiner DM, Harkins TT, Voss SR. Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration. Bmc Biology. 7: 1. PMID 19144100 DOI: 10.1186/1741-7007-7-1  0.781
2009 Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, Gage FH, Verma IM. Development of a novel mouse glioma model using lentiviral vectors. Nature Medicine. 15: 110-6. PMID 19122659 DOI: 10.1038/Nm.1863  0.344
2008 Tiscornia G, Singer O, Verma IM. Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version B. Csh Protocols. 2008: pdb.prot5010. PMID 21356885 DOI: 10.1101/Pdb.Prot5010  0.341
2008 Singer O, Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Current Gene Therapy. 8: 483-8. PMID 19075631 DOI: 10.2174/156652308786848067  0.361
2008 Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, Patrick C, Gage FH, Verma IM, Masliah E. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. Bmc Neuroscience. 9: 109. PMID 19014502 DOI: 10.1186/1471-2202-9-109  0.635
2008 Suzuki K, Verma IM. Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell. 134: 485-95. PMID 18692471 DOI: 10.1016/J.Cell.2008.05.050  0.321
2008 El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, Kindy MS. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. The American Journal of Pathology. 172: 1342-54. PMID 18403590 DOI: 10.2353/Ajpath.2008.070620  0.614
2008 Zhu Q, Pao G, Tonnu N, Verma IM. Abstract LB-330: A novel role of tumor suppressor BRCA1 in regulating integrity of heterochromatin structure. Cancer Research. 68. DOI: 10.1158/1538-7445.Am2008-Lb-330  0.797
2008 Marumoto T, Friedmann-Morvinski D, Yang M, Hoffman R, Verma I. Novel mouse glioma model: cell-type and region specific activation of oncogenes using lentiviral vectors Nature Protocols. DOI: 10.1038/Nprot.2008.207  0.316
2007 Singer O, Tiscornia G, Verma IM. Knockdown transgenic mice generated by silencing lentiviral vectors: zona pellucida removal and subzonal injection methods. Csh Protocols. 2007: pdb.prot4756. PMID 21357087 DOI: 10.1101/Pdb.Prot4756  0.311
2007 McLaughlin J, Cheng D, Singer O, Lukacs RU, Radu CG, Verma IM, Witte ON. Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proceedings of the National Academy of Sciences of the United States of America. 104: 20501-6. PMID 18079287 DOI: 10.1073/Pnas.0710532105  0.52
2007 Irelan JT, Murphy TJ, DeJesus PD, Teo H, Xu D, Gomez-Ferreria MA, Zhou Y, Miraglia LJ, Rines DR, Verma IM, Sharp DJ, Tergaonkar V, Chanda SK. A role for IkappaB kinase 2 in bipolar spindle assembly. Proceedings of the National Academy of Sciences of the United States of America. 104: 16940-5. PMID 17939994 DOI: 10.1073/Pnas.0706493104  0.348
2007 Michalkiewicz M, Michalkiewicz T, Geurts AM, Roman RJ, Slocum GR, Singer O, Weihrauch D, Greene AS, Kaldunski M, Verma IM, Jacob HJ, Cowley AW. Efficient transgenic rat production by a lentiviral vector. American Journal of Physiology. Heart and Circulatory Physiology. 293: H881-94. PMID 17322424 DOI: 10.1152/Ajpheart.00060.2007  0.333
2007 Hoffmann A, Xia Y, Verma IM. Inflammatory tales of liver cancer. Cancer Cell. 11: 99-101. PMID 17292819 DOI: 10.1016/J.Ccr.2007.01.008  0.512
2007 Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A. A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 128: 369-81. PMID 17254973 DOI: 10.1016/J.Cell.2006.12.033  0.515
2006 Singer O, Tiscornia G, Ikawa M, Verma IM. Rapid generation of knockdown transgenic mice by silencing lentiviral vectors. Nature Protocols. 1: 286-92. PMID 17406246 DOI: 10.1038/Nprot.2006.44  0.545
2006 Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nature Protocols. 1: 241-5. PMID 17406239 DOI: 10.1038/Nprot.2006.37  0.315
2006 Tiscornia G, Singer O, Verma IM. Design and cloning of lentiviral vectors expressing small interfering RNAs. Nature Protocols. 1: 234-40. PMID 17406238 DOI: 10.1038/Nprot.2006.36  0.362
2006 Ghosh S, Tergaonkar V, Rothlin CV, Correa RG, Bottero V, Bist P, Verma IM, Hunter T. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell. 10: 215-26. PMID 16959613 DOI: 10.1016/J.Ccr.2006.08.007  0.487
2006 Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM. Gene therapy: therapeutic gene causing lymphoma. Nature. 440: 1123. PMID 16641981 DOI: 10.1038/4401123A  0.315
2006 Tanaka N, Ikawa M, Mata NL, Verma IM. Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 609-16. PMID 16263331 DOI: 10.1016/J.Ymthe.2005.08.024  0.508
2006 Woods NB, Bottero V, Schmidt M, Von Kalle C, Verma IM. Gene therapy: Is IL2RG oncogenic in T-cell development?: X-SCID transgene leukaemogenicity (reply) Nature. 443: E6-E7. DOI: 10.1038/Nature05220  0.322
2006 Spencer BJ, Verma IM. 413. Targeting the Low-Density Lipoprotein Receptor on the Blood-Brain Barrier for Transport of β-Glucoronidase Can Treat the Neurological Degeneration of MPSVII Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.477  0.304
2006 Singer O, Marr RA, Rockenstein E, Crow L, Gage FH, Verma IM, Masliah E. 81. Hippocampal Gene Knockdown of BACE1 by Lentiviral Gene Transfer of siRNA Reduces Amyloid Pathology and Improves Memory Performance in APP Transgenic Mice Molecular Therapy. 13: S34. DOI: 10.1016/J.Ymthe.2006.08.099  0.645
2006 Woods N, Bottero V, Schmidt M, von Kalle C, Verma IM. 63. Long-Term Constitutive Expression of the Therapeutic Gene, IL2RG, Causes T-Cell Lymphomas in a Gene Therapy Model for XSCID Molecular Therapy. 13: S26-S27. DOI: 10.1016/J.Ymthe.2006.08.079  0.353
2005 Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, Ellison JA, Schadt EE, Verma IM, Lockhart DJ, Barlow C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature. 438: 662-6. PMID 16244648 DOI: 10.1038/Nature04250  0.596
2005 Li Q, Lu Q, Estepa G, Verma IM. Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proceedings of the National Academy of Sciences of the United States of America. 102: 15977-82. PMID 16239341 DOI: 10.1073/Pnas.0508310102  0.302
2005 Tergaonkar V, Correa RG, Ikawa M, Verma IM. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nature Cell Biology. 7: 921-3. PMID 16136188 DOI: 10.1038/Ncb1296  0.553
2005 Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma IM, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neuroscience. 8: 1343-9. PMID 16136043 DOI: 10.1038/Nn1531  0.626
2005 Li Q, Lu Q, Bottero V, Estepa G, Morrison L, Mercurio F, Verma IM. Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proceedings of the National Academy of Sciences of the United States of America. 102: 12425-30. PMID 16116086 DOI: 10.1073/Pnas.0505997102  0.306
2005 Correa RG, Matsui T, Tergaonkar V, Rodriguez-Esteban C, Izpisua-Belmonte JC, Verma IM. Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Current Biology : Cb. 15: 1291-5. PMID 16051172 DOI: 10.1016/J.Cub.2005.06.023  0.33
2005 Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annual Review of Biochemistry. 74: 711-38. PMID 15952901 DOI: 10.1146/Annurev.Biochem.74.050304.091637  0.316
2005 Li Q, Withoff S, Verma IM. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends in Immunology. 26: 318-25. PMID 15922948 DOI: 10.1016/J.It.2005.04.003  0.316
2005 Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 1211-6. PMID 15657137 DOI: 10.1073/Pnas.0409072102  0.627
2005 Wang L, Calcedo R, Nichols TC, Bellinger DA, Dillow A, Verma IM, Wilson JM. Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood. 105: 3079-86. PMID 15637142 DOI: 10.1182/Blood-2004-10-3867  0.314
2005 Galimi F, Saez E, Gall J, Hoong N, Cho G, Evans RM, Verma IM. Development of ecdysone-regulated lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 142-8. PMID 15585415 DOI: 10.1016/J.Ymthe.2004.08.021  0.366
2005 Singer O, Marr RA, Rockenstein E, Crews L, Gage FH, Verma IM, Masliah E. 56. Amelioration of Neurodegenerative and Neuropathological Alterations in a Transgenic Model of Alzheimer's Disease: Targeting BACE1 with Small Interfering RNAs Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.084  0.64
2004 Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, ... ... Verma IM, et al. The knockout mouse project. Nature Genetics. 36: 921-4. PMID 15340423 DOI: 10.1038/Ng0904-921  0.32
2004 Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F, Verma IM. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science (New York, N.Y.). 304: 1963-7. PMID 15218148 DOI: 10.1126/Science.1098387  0.771
2004 Tiscornia G, Tergaonkar V, Galimi F, Verma IM. CRE recombinase-inducible RNA interference mediated by lentiviral vectors Proceedings of the National Academy of Sciences of the United States of America. 101: 7347-7351. PMID 15123829 DOI: 10.1073/Pnas.0402107101  0.357
2004 Kankkonen HM, Vähäkangas E, Marr RA, Pakkanen T, Laurema A, Leppänen P, Jalkanen J, Verma IM, Ylä-Herttuala S. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 548-56. PMID 15093185 DOI: 10.1016/J.Ymthe.2004.01.015  0.63
2004 Singer O, Yanai A, Verma IM. Silence of the genes Proceedings of the National Academy of Sciences of the United States of America. 101: 5313-5314. PMID 15067116 DOI: 10.1073/Pnas.0401209101  0.33
2004 Marr RA, Guan H, Rockenstein E, Kindy M, Gage FH, Verma I, Masliah E, Hersh LB. Neprilysin regulates amyloid Beta peptide levels. Journal of Molecular Neuroscience : Mn. 22: 5-11. PMID 14742905 DOI: 10.1385/Jmn:22:1-2:5  0.627
2004 Woods NR, Tergaonkar V, Singer O, Bottero V, Verma IM. p53 Silencing by Lentiviral Vector Mediated RNA Interference in Murine Hematopoietic Cells and the Development of a Myelogenous Proliferative Disease. Blood. 104: 2572-2572. DOI: 10.1182/Blood.V104.11.2572.2572  0.346
2004 Singer O, Ikawa M, Hoong N, Campbell G, Verma IM. 994. Gene Knockdown in Mice by Using Lentiviral Vectors Expressing Small Interfering RNA Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.932  0.369
2004 Spencer BJ, Verma IM. 700. Targeted delivery of a recombinant protein to neurons and astrocytes by transport and uptake via the low density lipoprotein (LDL) receptor for treatment of neurodegenerative disorders Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.655  0.321
2004 Marr RA, Rockenstien E, Kindy MS, Hersh LB, Gage FH, Masliah E, Verma IM. 525. Therapy for Alzheimer's disease by neprilysin gene transfer Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.470  0.635
2004 Tanaka N, Michalakis S, Biel M, Hofmann F, Verma IM. 1057. Successful Gene Therapy for Retinal Degenerations by Lentiviral Gene Transfer Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.1002  0.309
2003 Tergaonkar V, Bottero V, Ikawa M, Li Q, Verma IM. IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy Molecular and Cellular Biology. 23: 8070-8083. PMID 14585967 DOI: 10.1128/Mcb.23.22.8070-8083.2003  0.566
2003 Ikawa M, Tanaka N, Kao WWY, Verma IM. Generation of transgenic mice using lentiviral vectors: A novel preclinical assessment of lectiviral vectors for gene therapy Molecular Therapy. 8: 666-673. PMID 14529840 DOI: 10.1016/S1525-0016(03)00240-5  0.56
2003 Shin S, Verma IM. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription Proceedings of the National Academy of Sciences of the United States of America. 100: 7201-7206. PMID 12756300 DOI: 10.1073/Pnas.1132020100  0.312
2003 Kootstra NA, Matsumura R, Verma IM. Efficient production of human FVIII in hemophilic mice using lentiviral vectors Molecular Therapy. 7: 623-631. PMID 12718905 DOI: 10.1016/S1525-0016(03)00073-X  0.381
2003 Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1992-6. PMID 12657655 DOI: 10.1523/Jneurosci.23-06-01992.2003  0.636
2003 Verma IM. A voluntary moratorium? Molecular Therapy. 7: 141. PMID 12638540 DOI: 10.1016/S1525-0016(03)00009-1  0.338
2003 Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA Proceedings of the National Academy of Sciences of the United States of America. 100: 1844-1848. PMID 12552109 DOI: 10.1073/Pnas.0437912100  0.55
2003 Xia Y, Pao GM, Chen HW, Verma IM, Hunter T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein Journal of Biological Chemistry. 278: 5255-5263. PMID 12431996 DOI: 10.1074/Jbc.M204591200  0.772
2003 Kootstra NA, Verma IM. Gene Therapy with Viral Vectors Annual Review of Pharmacology and Toxicology. 43: 413-439. PMID 12359866 DOI: 10.1146/Annurev.Pharmtox.43.100901.140257  0.316
2002 Li Q, Verma IM. NF-κB regulation in the immune system Nature Reviews Immunology. 2: 725-734. PMID 12360211 DOI: 10.1038/Nri910  0.323
2002 Pan D, Gunther R, Duan W, Wendell S, Kaemmerer W, Kafri T, Verma IM, Whitley CB. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 19-29. PMID 12095299 DOI: 10.1006/Mthe.2002.0630  0.316
2002 Ikawa M, Tergaonkar V, Ogura A, Ogonuki N, Inoue K, Verma IM. Restoration of spermatogenesis by lentiviral gene transfer: Offspring from infertile mice Proceedings of the National Academy of Sciences of the United States of America. 99: 7524-7529. PMID 12032316 DOI: 10.1073/Pnas.072207299  0.557
2002 Galimi F, Verma IM. Opportunities for the use of lentiviral vectors in human gene therapy Current Topics in Microbiology and Immunology. 261: 245-254. PMID 11892251 DOI: 10.1007/978-3-642-56114-6_13  0.318
2002 Leal AM, Takabe K, Wang L, Donaldson CJ, MacConell LA, Bilezikjian LM, Verma IM, Vale W. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology. 143: 964-9. PMID 11861519 DOI: 10.1210/Endo.143.3.8667  0.304
2002 Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos Proceedings of the National Academy of Sciences of the United States of America. 99: 2140-2145. PMID 11854510 DOI: 10.1073/Pnas.251682798  0.571
2002 Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, Gage FH. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proceedings of the National Academy of Sciences of the United States of America. 99: 2320-5. PMID 11842206 DOI: 10.1073/Pnas.042678699  0.729
2001 Pfeifer A, Verma IM. Gene therapy: Promises and problems Annual Review of Genomics and Human Genetics. 2: 177-211. PMID 11701648 DOI: 10.1146/Annurev.Genom.2.1.177  0.347
2001 Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM. Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo Proceedings of the National Academy of Sciences of the United States of America. 98: 11450-11455. PMID 11553794 DOI: 10.1073/Pnas.201415498  0.722
2001 McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q, Chen S, Chen FF, Yamaoka S, Verma IM, Mak TW, Núñez G. Bimp1, a MAGUK Family Member Linking Protein Kinase C Activation to Bcl10-mediated NF-κB Induction Journal of Biological Chemistry. 276: 30589-30597. PMID 11387339 DOI: 10.1074/Jbc.M103824200  0.329
2001 Ruffner H, Joazeiro CAP, Hemmati D, Hunter T, Verma IM. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity Proceedings of the National Academy of Sciences of the United States of America. 98: 5134-5139. PMID 11320250 DOI: 10.1073/Pnas.081068398  0.466
2001 Pfeifer A, Kessler T, Yang M, Baranov E, Kootstra N, Cheresh DA, Hoffman RM, Verma IM. Transduction of liver cells by lentiviral vectors: Analysis in living animals by fluorescence imaging Molecular Therapy. 3: 319-322. PMID 11273773 DOI: 10.1006/Mthe.2001.0276  0.322
2001 Xu K, Ma H, McCown TJ, Verma IM, Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 97-104. PMID 11162316 DOI: 10.1006/Mthe.2000.0238  0.341
2000 Naldini L, Verma IM. Lentiviral vectors. Advances in Virus Research. 55: 599-609. PMID 11050959  0.376
2000 Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma IM. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2 Proceedings of the National Academy of Sciences of the United States of America. 97: 12227-12232. PMID 11035804 DOI: 10.1073/Pnas.220399597  0.32
2000 Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 97: 11893-8. PMID 11027313 DOI: 10.1073/Pnas.220413297  0.34
2000 Kafri T, Van Praag H, Gage FH, Verma IM. Lentiviral vectors: Regulated gene expression Molecular Therapy. 1: 516-521. PMID 10933976 DOI: 10.1006/Mthe.2000.0083  0.372
2000 Wang L, Nichols TC, Read MS, Bellinger DA, Verma IM. Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver Molecular Therapy. 1: 154-158. PMID 10933925 DOI: 10.1006/Mthe.2000.0031  0.309
2000 Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. CBP/p300 interact with and function as transcriptional coactivators of BRCA1 Proceedings of the National Academy of Sciences of the United States of America. 97: 1020-1025. PMID 10655477 DOI: 10.1073/Pnas.97.3.1020  0.784
2000 Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. The Journal of Cell Biology. 148: 333-42. PMID 10648566 DOI: 10.1083/Jcb.148.2.333  0.301
2000 Li Q, Estepa G, Memet S, Israel A, Verma IM. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes & Development. 14: 1729-1733. DOI: 10.1101/Gad.14.14.1729  0.331
1999 Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma IM. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proceedings of the National Academy of Sciences of the United States of America. 96: 12667-72. PMID 10535980 DOI: 10.1073/Pnas.96.22.12667  0.315
1999 Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Molecular and Cellular Biology. 19: 4843-54. PMID 10373534 DOI: 10.1128/Mcb.19.7.4843  0.453
1999 Li Q, Lu Q, Hwang JY, Büscher D, Lee KF, Izpisua-Belmonte JC, Verma IM. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes & Development. 13: 1322-8. PMID 10346820 DOI: 10.1101/Gad.13.10.1322  0.312
1999 Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (New York, N.Y.). 284: 321-5. PMID 10195897 DOI: 10.1126/Science.284.5412.321  0.345
1999 Wang L, Takabe K, Bidlingmaier SM, Ill CR, Verma IM. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 96: 3906-10. PMID 10097136 DOI: 10.1073/Pnas.96.7.3906  0.329
1999 Somia NV, Kafri T, Verma IM. Piecing together more efficient gene expression Nature Biotechnology. 17: 224-225. PMID 10096283 DOI: 10.1038/6962  0.312
1999 Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (New York, N.Y.). 283: 682-6. PMID 9924027 DOI: 10.1126/Science.283.5402.682  0.329
1999 Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM. A packaging cell line for lentivirus vectors. Journal of Virology. 73: 576-84. PMID 9847362 DOI: 10.1128/Jvi.73.1.576-584.1999  0.32
1999 Takahashi M, Miyoshi H, Verma IM, Gage FH. Rescue from Photoreceptor Degeneration in therd Mouse by Human Immunodeficiency Virus Vector-Mediated Gene Transfer Journal of Virology. 73: 7812-7816. DOI: 10.1128/Jvi.73.9.7812-7816.1999  0.311
1999 Naldini L, Verma IM. 3 Lentiviral Vectors Cold Spring Harbor Monograph Archive. 36: 47-60. DOI: 10.1101/087969528.36.47  0.538
1998 Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 95: 11377-82. PMID 9736744 DOI: 10.1073/Pnas.95.19.11377  0.341
1998 Van Antwerp DJ, Martin SJ, Verma IM, Green DR. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends in Cell Biology. 8: 107-11. PMID 9695819 DOI: 10.1016/S0962-8924(97)01215-4  0.327
1998 Kanegae Y, Tavares AT, Izpisúa Belmonte JC, Verma IM. Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb. Nature. 392: 611-4. PMID 9560158 DOI: 10.1038/33429  0.358
1998 Schwarz EM, Badorff C, Hiura TS, Wessely R, Badorff A, Verma IM, Knowlton KU. NF-κB-Mediated Inhibition of Apoptosis Is Required for Encephalomyocarditis Virus Virulence: a Mechanism of Resistance in p50 Knockout Mice Journal of Virology. 72: 5654-5660. DOI: 10.1128/Jvi.72.7.5654-5660.1998  0.308
1998 Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM. Development of a Self-Inactivating Lentivirus Vector Journal of Virology. 72: 8150-8157. DOI: 10.1128/Jvi.72.10.8150-8157.1998  0.355
1997 Kafri T, Blömer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genetics. 17: 314-7. PMID 9354796 DOI: 10.1038/Ng1197-314  0.342
1997 Verma IM, Stevenson J. IkappaB kinase: beginning, not the end. Proceedings of the National Academy of Sciences of the United States of America. 94: 11758-60. PMID 9342307 DOI: 10.1073/Pnas.94.22.11758  0.349
1997 Wang L, Zoppè M, Hackeng TM, Griffin JH, Lee KF, Verma IM. A factor IX-deficient mouse model for hemophilia B gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 94: 11563-6. PMID 9326649 DOI: 10.1073/Pnas.94.21.11563  0.328
1997 Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proceedings of the National Academy of Sciences of the United States of America. 94: 10319-23. PMID 9294208 DOI: 10.1073/Pnas.94.19.10319  0.311
1997 Blömer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Journal of Virology. 71: 6641-9. PMID 9261386 DOI: 10.1128/Jvi.71.9.6641-6649.1997  0.533
1997 Tashiro K, Pando MP, Kanegae Y, Wamsley PM, Inoue S, Verma IM. Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IκBα Proceedings of the National Academy of Sciences of the United States of America. 94: 7862-7867. PMID 9223278 DOI: 10.1073/Pnas.94.15.7862  0.303
1997 Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proceedings of the National Academy of Sciences of the United States of America. 94: 7138-43. PMID 9207057 DOI: 10.1073/Pnas.94.14.7138  0.325
1997 Carrozza ML, Jacobs H, Acton D, Verma I, Berns A. Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells. Oncogene. 14: 1083-91. PMID 9070657 DOI: 10.1038/Sj.Onc.1200921  0.318
1997 Blömer U, Kafri T, Naldini L, Verma I, Gage F. Efficient and sustained gene transfer in terminally differentiated cells with a lentiviral vector European Journal of Cancer. 33: S51. DOI: 10.1016/S0959-8049(97)89458-0  0.509
1996 Naldini L, Blömer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proceedings of the National Academy of Sciences of the United States of America. 93: 11382-8. PMID 8876144 DOI: 10.1073/Pnas.93.21.11382  0.516
1996 Blömer U, Naldini L, Verma IM, Trono D, Gage FH. Applications of gene therapy to the CNS. Human Molecular Genetics. 5: 1397-404. PMID 8875243 DOI: 10.1093/Hmg/5.Supplement_1.1397  0.52
1996 Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (New York, N.Y.). 272: 263-7. PMID 8602510 DOI: 10.1126/Science.272.5259.263  0.634
1996 Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. Journal of Virology. 70: 5701-5705. DOI: 10.1128/Jvi.70.8.5701-5705.1996  0.37
1995 Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proceedings of the National Academy of Sciences of the United States of America. 92: 1401-5. PMID 7877990 DOI: 10.1073/Pnas.92.5.1401  0.322
1995 Somia NV, Zoppé M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proceedings of the National Academy of Sciences of the United States of America. 92: 7570-4. PMID 7638232 DOI: 10.1073/Pnas.92.16.7570  0.344
1995 Miyamoto S, Verma IM. Rel/NF-kappa B/I kappa B story. Advances in Cancer Research. 66: 255-292. DOI: 10.1016/S0065-230X(08)60257-2  0.37
1994 Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 91: 5056-60. PMID 8197184 DOI: 10.1073/Pnas.91.11.5056  0.307
1993 Wisdom R, Verma IM. Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation. Molecular and Cellular Biology. 13: 2635-43. PMID 8474434 DOI: 10.1128/Mcb.13.5.2635  0.309
1993 Kerr LD, Ransone LJ, Wamsley P, Schmitt MJ, Boyer TG, Zhou Q, Berk AJ, Verma IM. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B. Nature. 365: 412-9. PMID 8413585 DOI: 10.1038/365412A0  0.319
1992 Verma IM, Naviaux RK. Human gene therapy. Current Opinion in Genetics & Development. 1: 54-9. PMID 1840879 DOI: 10.1016/0959-437X(91)80041-J  0.304
1992 Inoue J, Kerr LD, Rashid D, Davis N, Bose HR, Verma IM. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proceedings of the National Academy of Sciences of the United States of America. 89: 4333-7. PMID 1533932 DOI: 10.1073/Pnas.89.10.4333  0.326
1992 Kerr LD, Inoue J, Verma IM. Signal transduction: the nuclear target. Current Opinion in Cell Biology. 4: 496-501. PMID 1497922 DOI: 10.1016/0955-0674(92)90017-7  0.345
1992 Wisdom R, Yen J, Rashid D, Verma IM. Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes & Development. 6: 667-75. PMID 1373118 DOI: 10.1101/Gad.6.4.667  0.318
1992 Naviaux RK, Verma IM. Retroviral vectors for persistent expression in vivo. Current Opinion in Biotechnology. 3: 540-7. PMID 1368938 DOI: 10.1016/0958-1669(92)90083-U  0.335
1992 Inoue J, Kerr LD, Kakizuka A, Verma IM. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell. 68: 1109-20. PMID 1339305 DOI: 10.1016/0092-8674(92)90082-N  0.319
1992 Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proceedings of the National Academy of Sciences of the United States of America. 89: 10892-5. PMID 1332058 DOI: 10.1073/Pnas.89.22.10892  0.352
1992 Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, Verma IM. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell. 68: 507-19. PMID 1310896 DOI: 10.1016/0092-8674(92)90187-H  0.347
1991 Inoue J, Kerr LD, Ransone LJ, Bengal E, Hunter T, Verma IM. c-rel activates but v-rel suppresses transcription from kappa B sites. Proceedings of the National Academy of Sciences of the United States of America. 88: 3715-9. PMID 2023921 DOI: 10.1073/Pnas.88.9.3715  0.479
1991 Yen J, Wisdom RM, Tratner I, Verma IM. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proceedings of the National Academy of Sciences of the United States of America. 88: 5077-81. PMID 1905017 DOI: 10.1073/Pnas.88.12.5077  0.321
1991 Scharfmann R, Axelrod JH, Verma IM. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proceedings of the National Academy of Sciences of the United States of America. 88: 4626-30. PMID 1905011 DOI: 10.1073/Pnas.88.11.4626  0.333
1991 Weintraub H, Dwarki VJ, Verma I, Davis R, Hollenberg S, Snider L, Lassar A, Tapscott SJ. Muscle-specific transcriptional activation by MyoD. Genes & Development. 5: 1377-86. PMID 1651276 DOI: 10.1101/Gad.5.8.1377  0.327
1991 Schüle R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM. Retinoic acid is a negative regulator of AP-1-responsive genes. Proceedings of the National Academy of Sciences of the United States of America. 88: 6092-6. PMID 1648728 DOI: 10.1073/Pnas.88.14.6092  0.325
1990 Bull P, Hunter T, Verma IM. Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts. Molecular and Cellular Biology. 9: 5239-43. PMID 2601720 DOI: 10.1128/Mcb.9.11.5239  0.465
1990 Axelrod JH, Read MS, Brinkhous KM, Verma IM. Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proceedings of the National Academy of Sciences of the United States of America. 87: 5173-7. PMID 2367529 DOI: 10.1073/Pnas.87.13.5173  0.314
1990 Li CL, Dwarki VJ, Verma IM. Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses. Proceedings of the National Academy of Sciences of the United States of America. 87: 4349-53. PMID 2349242 DOI: 10.1073/Pnas.87.11.4349  0.351
1990 Bull P, Morley KL, Hoekstra MF, Hunter T, Verma IM. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Molecular and Cellular Biology. 10: 5473-85. PMID 2204816 DOI: 10.1128/Mcb.10.10.5473  0.472
1990 Wisdom R, Verma IM. Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant. Molecular and Cellular Biology. 10: 5626-33. PMID 2172782 DOI: 10.1128/Mcb.10.11.5626  0.323
1990 Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 62: 1217-26. PMID 2169353 DOI: 10.1016/0092-8674(90)90397-W  0.334
1990 Lamph WW, Dwarki VJ, Ofir R, Montminy M, Verma IM. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proceedings of the National Academy of Sciences of the United States of America. 87: 4320-4. PMID 2140898 DOI: 10.1073/Pnas.87.11.4320  0.308
1990 Tratner I, De Togni P, Sassone-Corsi P, Verma IM. Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector. Journal of Virology. 64: 499-508. DOI: 10.1128/Jvi.64.2.499-508.1990  0.327
1990 Dwarki V, Montminy M, Verma I. Both the basic region and the ‘leucine zipper’ domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation. The Embo Journal. 9: 225-232. DOI: 10.1002/J.1460-2075.1990.Tb08099.X  0.323
1989 Sassone-Corsi P, Lamph WW, Verma IM. Regulation of proto-oncogene fos: a paradigm for early response genes. Cold Spring Harbor Symposia On Quantitative Biology. 749-60. PMID 3151187 DOI: 10.1101/Sqb.1988.053.01.085  0.306
1989 Sassone-Corsi P, Ransone LJ, Lamph WW, Verma IM. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature. 336: 692-5. PMID 3143919 DOI: 10.1038/336692A0  0.351
1989 Visvader J, Verma IM. Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Molecular and Cellular Biology. 9: 1336-41. PMID 2524648 DOI: 10.1128/Mcb.9.3.1336  0.359
1989 Fujii M, Shalloway D, Verma IM. Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos Molecular and Cellular Biology. 9: 2493-2499. PMID 2474755 DOI: 10.1128/Mcb.9.6.2493  0.312
1988 St Louis D, Verma IM. An alternative approach to somatic cell gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 85: 3150-4. PMID 3283738 DOI: 10.1073/Pnas.85.9.3150  0.327
1988 Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 54: 553-60. PMID 3135941 DOI: 10.1016/0092-8674(88)90077-3  0.615
1988 Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma IM. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes & Development. 2: 1529-38. PMID 2850967 DOI: 10.1101/Gad.2.12A.1529  0.36
1988 Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proceedings of the National Academy of Sciences of the United States of America. 85: 8526-30. PMID 2847164 DOI: 10.1073/Pnas.85.22.8526  0.348
1988 Sassone-Corsi P, Sisson JC, Verma IM. Transcriptional autoregulation of the proto-oncogene fos. Nature. 334: 314-9. PMID 2839774 DOI: 10.1038/334314A0  0.306
1988 Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 334: 629-31. PMID 2457172 DOI: 10.1038/334629A0  0.381
1987 Van Beveren C, Mitchell RL, Henning-Chubb C, Huberman E, Verma IM. Expression of the c-fos gene during differentiation. Advances in Experimental Medicine and Biology. 213: 263-74. PMID 3630828 DOI: 10.1007/978-1-4684-5323-2_26  0.36
1987 Sassone-Corsi P, Verma IM. Modulation of c-fos gene transcription by negative and positive cellular factors. Nature. 326: 507-10. PMID 3561489 DOI: 10.1038/326507A0  0.372
1987 Verma IM, Deschamps J, Van Beveren C, Sassone-Corsi P. Human fos gene. Cold Spring Harbor Symposia On Quantitative Biology. 949-58. PMID 3555978 DOI: 10.1101/Sqb.1986.051.01.108  0.306
1987 Botteri FM, van der Putten H, Miller AD, Fan H, Verma IM. Recombinant retroviruses in transgenic mice. Annals of the New York Academy of Sciences. 478: 255-68. PMID 3541752 DOI: 10.1111/J.1749-6632.1986.Tb15536.X  0.42
1987 Billestrup N, Mitchell RL, Vale W, Verma IM. Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells. Molecular Endocrinology (Baltimore, Md.). 1: 300-5. PMID 3135482 DOI: 10.1210/Mend-1-4-300  0.319
1987 McIvor RS, Johnson MJ, Miller AD, Pitts S, Williams SR, Valerio D, Martin DW, Verma IM. Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses. Molecular and Cellular Biology. 7: 838-46. PMID 3102947 DOI: 10.1128/MCB.7.2.838  0.442
1987 Barber JR, Sassone-Corsi P, Verma IM. Proto-oncogene fos: factors affecting expression and covalent modification of the gene product. Annals of the New York Academy of Sciences. 511: 117-30. PMID 2830821 DOI: 10.1111/J.1749-6632.1987.Tb36242.X  0.344
1986 Van Beveren C, Verma IM. Homology among oncogenes. Current Topics in Microbiology and Immunology. 123: 73-98. PMID 3004831 DOI: 10.1007/978-3-642-70810-7_4  0.335
1986 Verma IM. Proto-oncogene fos: a multifaceted gene Trends in Genetics. 2: 93-96. DOI: 10.1016/0168-9525(86)90191-5  0.305
1985 Kruijer W, Cooper JA, Hunter T, Verma IM. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature. 312: 711-6. PMID 6514007 DOI: 10.1038/312711A0  0.457
1985 Curran T, Van Beveren C, Verma IM. Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein. Molecular and Cellular Biology. 5: 167-72. PMID 3885008 DOI: 10.1128/Mcb.5.1.167  0.514
1985 Mitchell RL, Zokas L, Schreiber RD, Verma IM. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell. 40: 209-17. PMID 3881183 DOI: 10.1016/0092-8674(85)90324-1  0.302
1985 Deschamps J, Meijlink F, Verma IM. Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. Science (New York, N.Y.). 230: 1174-7. PMID 3865371 DOI: 10.1126/Science.3865371  0.347
1985 van der Putten H, Botteri FM, Miller AD, Rosenfeld MG, Fan H, Evans RM, Verma IM. Efficient insertion of genes into the mouse germ line via retroviral vectors. Proceedings of the National Academy of Sciences of the United States of America. 82: 6148-52. PMID 3862122 DOI: 10.1073/Pnas.82.18.6148  0.494
1985 Kruijer W, Schubert D, Verma IM. Induction of the proto-oncogene fos by nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America. 82: 7330-4. PMID 2997786 DOI: 10.1073/Pnas.82.21.7330  0.305
1985 Meijlink F, Curran T, Miller AD, Verma IM. Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. Proceedings of the National Academy of Sciences of the United States of America. 82: 4987-91. PMID 2991903 DOI: 10.1073/Pnas.82.15.4987  0.626
1985 Miller AD, Law MF, Verma IM. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Molecular and Cellular Biology. 5: 431-7. PMID 2985952 DOI: 10.1128/Mcb.5.3.431  0.475
1985 Miller AD, Verma IM, Curran T. Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity. Journal of Virology. 55: 521-526. DOI: 10.1128/jvi.55.3.521-526.1985  0.347
1984 Dusty Miller A, Curran T, Verma IM. c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene Cell. 36: 51-60. PMID 6607118 DOI: 10.1016/0092-8674(84)90073-4  0.517
1984 Slamon DJ, deKernion JB, Verma IM, Cline MJ. Expression of cellular oncogenes in human malignancies. Science (New York, N.Y.). 224: 256-62. PMID 6538699 DOI: 10.1126/Science.6538699  0.304
1984 Miller AD, Eckner RJ, Jolly DJ, Friedmann T, Verma IM. Expression of a retrovirus encoding human HPRT in mice. Science (New York, N.Y.). 225: 630-2. PMID 6377498 DOI: 10.1126/Science.6377498  0.488
1984 Lin CR, Chen WS, Kruiger W, Stolarsky LS, Weber W, Evans RM, Verma IM, Gill GN, Rosenfeld MG. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (New York, N.Y.). 224: 843-8. PMID 6326261 DOI: 10.1126/Science.6326261  0.331
1984 Curran T, Miller AD, Zokas L, Verma IM. Viral and cellular fos proteins: a comparative analysis. Cell. 36: 259-68. PMID 6319013 DOI: 10.1016/0092-8674(84)90219-8  0.639
1984 MacConnell WP, Verma IM. Expression of FBJ-MSV oncogene (fos) product in bacteria. Virology. 131: 367-74. PMID 6318437 DOI: 10.1016/0042-6822(83)90504-4  0.308
1984 Van Beveren C, Enami S, Curran T, Verma IM. FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology. 135: 229-43. PMID 6203215 DOI: 10.1016/0042-6822(84)90133-8  0.555
1984 Curran T, Verma IM. FBR murine osteosarcoma virus I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product Virology. 135: 218-228. PMID 6203214 DOI: 10.1016/0042-6822(84)90132-6  0.572
1984 Miller AD, Verma IM. Two base changes restore infectivity to a noninfectious molecular clone of moloney murine leukemia virus (pMLV-1) Journal of Virology. 49: 214-222. PMID 6197537 DOI: 10.1128/Jvi.49.1.214-222.1984  0.473
1984 Miller AD, Ong ES, Rosenfeld MG, Verma IM, Evans RM. Infectious and selectable retrovirus containing an inducible rat growth hormone minigene. Science (New York, N.Y.). 225: 993-8. PMID 6089340 DOI: 10.1126/Science.6089340  0.454
1984 Miller AD, Verma IM. Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus (pMLV-1). Journal of Virology. 49: 214-222. DOI: 10.1128/jvi.49.1.214-222.1984  0.321
1983 Müller R, Tremblay JM, Adamson ED, Verma IM. Tissue and cell type-specific expression of two human c-onc genes. Nature. 304: 454-6. PMID 6877368 DOI: 10.1038/304454A0  0.371
1983 van Straaten F, Müller R, Curran T, Van Beveren C, Verma IM. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proceedings of the National Academy of Sciences of the United States of America. 80: 3183-7. PMID 6574479 DOI: 10.1073/Pnas.80.11.3183  0.557
1983 Miller AD, Jolly DJ, Friedmann T, Verma IM. A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. Proceedings of the National Academy of Sciences of the United States of America. 80: 4709-13. PMID 6308645 DOI: 10.1073/Pnas.80.15.4709  0.509
1983 Müller R, Slamon DJ, Adamson ED, Tremblay JM, Müller D, Cline MJ, Verma IM. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Molecular and Cellular Biology. 3: 1062-9. PMID 6308423 DOI: 10.1128/Mcb.3.6.1062  0.309
1983 Curran T, MacConnell WP, van Straaten F, Verma IM. Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells. Molecular and Cellular Biology. 3: 914-21. PMID 6306448 DOI: 10.1128/Mcb.3.5.914  0.549
1983 Van Beveren C, van Straaten F, Curran T, Müller R, Verma IM. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 32: 1241-55. PMID 6301687 DOI: 10.1016/0092-8674(83)90306-9  0.55
1983 Jolly DJ, Esty AC, Subramani S, Friedmann T, Verma IM. Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. Nucleic Acids Research. 11: 1855-72. PMID 6300781 DOI: 10.1093/Nar/11.6.1855  0.351
1983 Müller R, Verma I, Adamson E. Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. The Embo Journal. 2: 679-684. DOI: 10.1002/J.1460-2075.1983.Tb01484.X  0.306
1982 Bosselman RA, van Straaten F, Van Beveren C, Verma IM, Vogt M. Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA. Journal of Virology. 44: 19-31. PMID 7143566 DOI: 10.1128/Jvi.44.1.19-31.1982  0.323
1982 Curran T, Peters G, Van Beveren C, Teich NM, Verma IM. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. Journal of Virology. 44: 674-82. PMID 6292525 DOI: 10.1128/Jvi.44.2.674-682.1982  0.56
1982 Müller R, Slamon DJ, Tremblay JM, Cline MJ, Verma IM. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature. 299: 640-4. PMID 6289129 DOI: 10.1038/299640A0  0.352
1982 Papkoff J, Verma IM, Hunter T. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus. Cell. 29: 417-26. PMID 6288258 DOI: 10.1016/0092-8674(82)90158-1  0.48
1982 Doehmer J, Barinaga M, Vale W, Rosenfeld MG, Verma IM, Evans RM. Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. Proceedings of the National Academy of Sciences of the United States of America. 79: 2268-72. PMID 6285377 DOI: 10.1073/Pnas.79.7.2268  0.327
1982 van der Putten H, Quint W, Verma IM, Berns A. Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions. Nucleic Acids Research. 10: 577-92. PMID 6278422 DOI: 10.1093/Nar/10.2.577  0.335
1982 Papkoff J, Lai MH, Hunter T, Verma IM. Analysis of transforming gene products from Moloney murine sarcoma virus. Cell. 27: 109-19. PMID 6276018 DOI: 10.1016/0092-8674(81)90365-2  0.486
1982 Van Beveren C, van Straaten F, Galleshaw JA, Verma IM. Nucleotide sequence of the genome of a murine sarcoma virus. Cell. 27: 97-108. PMID 6173134 DOI: 10.1016/0092-8674(81)90364-0  0.34
1981 Putten Hvd, Quint W, Raaij Jv, Maandag ER, Verma IM, Berns A. M-MuLV-induced leukemogenesis: Integration and structure of recombinant proviruses in tumors Cell. 24: 729-739. PMID 7249080 DOI: 10.1016/0092-8674(81)90099-4  0.302
1980 Lai MH, Verma IM. Genome organization of retroviruses. VIII. Nonproducer cell lines of mouse fibroblasts transformed by Moloney murine sarcoma virus DNA synthesized in vitro. Virology. 104: 407-17. PMID 7395109 DOI: 10.1016/0042-6822(80)90343-8  0.31
1980 Lai MH, Verma IM. Genome organization of retroviruses. VII. Infection by double-stranded DNA synthesized in vitro from Moloney murine leukemia virus generates a virus indistinguishable from the original virus used in reverse transcription. Virology. 100: 194-8. PMID 6153135 DOI: 10.1016/0042-6822(80)90567-X  0.302
1975 Panet A, Verma IM, Baltimore D. Role of the subunits of the avian RNA tumor virus reverse transcriptase. Cold Spring Harbor Symposia On Quantitative Biology. 39: 919-23. PMID 50898 DOI: 10.1101/Sqb.1974.039.01.107  0.365
1974 Forget BG, Marotta CA, Weissman SM, Verma IM, McCaffrey RP, Baltimore D. Nucleotide sequences of human globin messenger RNA. Annals of the New York Academy of Sciences. 241: 290-309. PMID 4611306  0.347
1974 Forget BG, Baltimore D, Benz EJ, Housman D, Lebowitz P, Marotta CA, McCaffrey RP, Skoultchi A, Swerdlow PS, Verma IM, Weissman SM. Globin messenger RNA in the thalassemia syndromes. Annals of the New York Academy of Sciences. 232: 76-87. PMID 4606589 DOI: 10.1111/J.1749-6632.1974.Tb20574.X  0.312
1974 Baltimore D, Verma IM, Drost S, Mason WS. Temperature-sensitive DNA polymerase from Rous sarcoma virus mutants. Cancer. 34: suppl:1395-7. PMID 4370959 DOI: 10.1002/1097-0142(197410)34:8+<1395::Aid-Cncr2820340810>3.0.Co;2-U  0.382
1974 Verma IM, Firtel RA, Lodish HF, Baltimore D. Synthesis of DNA complementary to cellular slime mold messenger RNA by reverse transcriptase. Biochemistry. 13: 3917-22. PMID 4137959 DOI: 10.1021/Bi00716A016  0.348
1974 Verma IM, Mason WS, Drost SD, Baltimore D. DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile. Nature. 251: 27-31. PMID 4137615 DOI: 10.1038/251027A0  0.372
1974 Verma IM, Baltimore D. Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates. Methods in Enzymology. 29: 125-30. PMID 4137148 DOI: 10.1016/0076-6879(74)29015-3  0.451
1974 Marotta CA, Forget BG, Weissman SM, Verma IM, McCaffrey RP, Baltimore D. Nucleotide sequences of human globin messenger RNA. Proceedings of the National Academy of Sciences of the United States of America. 71: 2300-4. PMID 4135409 DOI: 10.1073/Pnas.71.6.2300  0.447
1974 Verma IM, Meuth NL, Fan H, Baltimore D. Hamster leukemia virus: lack of endogenous DNA synthesis and unique structure of its DNA polymerase. Journal of Virology. 13: 1075-82. PMID 4132918 DOI: 10.1128/Jvi.13.5.1075-1082.1974  0.454
1973 Baltimore D, Verma IM, Smoler DF, Meuth NL. Avian myeloblastosis virus DNA polymerase: initiation of DNA synthesis and an associated ribonuclease. Johns Hopkins Medical Journal. Supplement. 2: 193-8. PMID 4369800  0.351
1972 Verma IM, Meuth NL, Baltimore D. Covalent linkage between ribonucleic Acid primer and deoxyribonucleic Acid product of the avian myeloblastosis virus deoxyribonucleic Acid polymerase. Journal of Virology. 10: 622-7. PMID 16789134 DOI: 10.1128/Jvi.10.4.622-627.1972  0.363
1972 Verma IM, Temple GF, Fan H, Baltimore D. In vitro synthesis of DNA complementary to rabbit reticulocyte 10S RNA. Nature: New Biology. 235: 163-7. PMID 4334193 DOI: 10.1038/Newbio235163A0  0.383
1971 Verma IM, Kay CM, Littauer UZ. Circular dichroism of mitochondrial ribosomal RNA from Trichoderma viride. Febs Letters. 12: 317-321. PMID 11945608 DOI: 10.1016/0014-5793(71)80004-2  0.466
1971 Verma IM, Edelman M, Littauer UZ. A comparison of nucleotide sequences from mitochondrial and cytoplasmic ribosomal RNA of Aspergillus nidulans. European Journal of Biochemistry / Febs. 19: 124-9. PMID 5551626 DOI: 10.1111/J.1432-1033.1971.Tb01295.X  0.479
1971 Edelman M, Verma IM, Saya D, Littauer UZ. Optical absorbance properties of mitochondrial ribosomal RNA. Biochemical and Biophysical Research Communications. 42: 208-13. PMID 5545512 DOI: 10.1016/0006-291X(71)90089-1  0.47
1971 Edelman M, Verma IM, Herzog R, Galun E, Littauer UZ. Physico-chemical properties of mitochondrial ribosomal RNA from fungi. European Journal of Biochemistry / Febs. 19: 372-8. PMID 5102922 DOI: 10.1111/J.1432-1033.1971.Tb01326.X  0.465
1971 Verma IM, Meuth NL, Bromfeld E, Manly KF, Baltimore D. Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase. Nature: New Biology. 233: 131-4. PMID 4330073 DOI: 10.1038/Newbio233131A0  0.353
1970 Verma IM, Edelman M, Herzberg M, Littauer UZ. Size determination of mitochondrial ribosomal RNA from Aspergillus nidulans by electron microscopy. Journal of Molecular Biology. 52: 137-40. PMID 4922208 DOI: 10.1016/0022-2836(70)90184-1  0.473
1970 Edelman M, Verma IM, Littauer UZ. Mitochondrial ribosomal RNA from Aspergillus nidulans: characterization of a novel molecular species. Journal of Molecular Biology. 49: 67-83. PMID 4915865 DOI: 10.1016/0022-2836(70)90376-1  0.477
Low-probability matches (unlikely to be authored by this person)
1993 Kerr LD, Duckett CS, Wamsley P, Zhang Q, Chiao P, Nabel G, McKeithan TW, Baeuerle PA, Verma IM. The proto-oncogene bcl-3 encodes an I kappa B protein. Genes & Development. 6: 2352-63. PMID 1459457 DOI: 10.1101/Gad.6.12A.2352  0.299
1992 Naughton BA, Dai Y, Sibanda B, Scharfmann R, Roman JS, Zeigler F, Verma IM. Long-term expression of a retrovirally introduced β-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes Somatic Cell and Molecular Genetics. 18: 451-462. PMID 1475711 DOI: 10.1007/Bf01233085  0.298
1994 Bengal E, Flores O, Rangarajan PN, Chen A, Weintraub H, Verma IM. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proceedings of the National Academy of Sciences of the United States of America. 91: 6221-5. PMID 8016142 DOI: 10.1073/Pnas.91.13.6221  0.298
1992 Roman M, Axelrod JH, Dai Y, Naviaux RK, Friedmann T, Verma IM. Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somatic Cell and Molecular Genetics. 18: 247-58. PMID 1496420 DOI: 10.1007/Bf01233861  0.298
1982 Fuhrman SA, Van Beveren C, Verma IM. Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA. Proceedings of the National Academy of Sciences of the United States of America. 78: 5411-5. PMID 6946480 DOI: 10.1073/Pnas.78.9.5411  0.297
2004 Correa RG, Tergaonkar V, Ng JK, Dubova I, Izpisua-Belmonte JC, Verma IM. Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development. Molecular and Cellular Biology. 24: 5257-68. PMID 15169890 DOI: 10.1128/Mcb.24.12.5257-5268.2004  0.297
2011 Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 4274-80. PMID 21262804 DOI: 10.1073/Pnas.1016030108  0.296
2011 Moraghebi R, Rönn RE, Stolz C, Guerrero PC, Parker A, Herbst A, Larsson M, Sitnicka E, Verma I, Woods N. Comparative Study of Hematopoietic Lineage Potential of Ips Cells Derived From Two Mesodermal Cell Lineages Blood. 118: 1285-1285. DOI: 10.1182/Blood.V118.21.1285.1285  0.295
2009 Raya A, Rodríguez-Pizà I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castellà M, Río P, Sleep E, González F, Tiscornia G, Garreta E, Aasen T, Veiga A, ... Verma IM, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 460: 53-9. PMID 19483674 DOI: 10.1038/Nature08129  0.295
1981 Van Beveren C, Galleshaw JA, Jonas V, Berns AJ, Doolittle RF, Donoghue DJ, Verma IM. Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus. Nature. 289: 258-62. PMID 6256659 DOI: 10.1038/289258A0  0.295
1980 Verma IM, Lai MH, Bosselman RA, McKennett MA, Fan H, Berns A. Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda. Proceedings of the National Academy of Sciences of the United States of America. 77: 1773-7. PMID 6445561 DOI: 10.1073/Pnas.77.4.1773  0.295
2002 Verma IM. Do not ban therapeutic cloning Molecular Therapy. 5: 651. PMID 12027544 DOI: 10.1006/Mthe.2002.0614  0.295
1990 Ransone LJ, Wamsley P, Morley KL, Verma IM. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins. Molecular and Cellular Biology. 10: 4565-73. PMID 2143806 DOI: 10.1128/Mcb.10.9.4565  0.293
1991 Kerr LD, Inoue J, Davis N, Link E, Baeuerle PA, Bose HR, Verma IM. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes & Development. 5: 1464-76. PMID 1907941 DOI: 10.1101/Gad.5.8.1464  0.293
1992 Tratner I, Ofir R, Verma IM. Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential. Molecular and Cellular Biology. 12: 998-1006. PMID 1545828 DOI: 10.1128/Mcb.12.3.998  0.293
2002 MacKenzie TC, Kobinger GP, Kootstra NA, Radu A, Sena-Esteves M, Bouchard S, Wilson JM, Verma IM, Flake AW. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes Molecular Therapy. 6: 349-358. PMID 12231171 DOI: 10.1006/Mthe.2002.0681  0.293
1998 Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis Human Gene Therapy. 9: 2717-2726. PMID 9874270 DOI: 10.1089/Hum.1998.9.18-2717  0.293
1992 Naviaux RK, Verma IM. Retroviral vectors for persistent expression in vivo Current Biology. 2: 668. DOI: 10.1016/0960-9822(92)90133-U  0.292
1988 Visvader J, Sassone-Corsi P, Verma IM. Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes. Proceedings of the National Academy of Sciences of the United States of America. 85: 9474-8. PMID 2849107 DOI: 10.1073/Pnas.85.24.9474  0.292
1996 Miyamoto S, Cauley K, Verma IM. Ultraviolet cross-linking of DNA binding proteins. Methods in Enzymology. 254: 632-41. PMID 8531720 DOI: 10.1016/0076-6879(95)54045-8  0.292
1994 Cauley K, Verma IM. Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 91: 390-4. PMID 8278399 DOI: 10.1073/Pnas.91.1.390  0.291
1986 Mitchell RL, Henning-Chubb C, Huberman E, Verma IM. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell. 45: 497-504. PMID 3085953 DOI: 10.1016/0092-8674(86)90281-3  0.291
2005 Wang L, Calcedo R, Nichols TC, Verma IM, Wilson JM. 1081. Sustained Correction of Disease in Na|[iuml]|ve and AAV2-Pretreated Hemophilia B Dogs Using Pseudotyped AAV Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.628  0.291
1996 Chapman MS, Verma IM. Transcriptional activation by BRCA1 Nature. 382: 678-679. PMID 8751436 DOI: 10.1038/382678A0  0.291
1994 Miyamoto S, Chiao PJ, Verma IM. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Molecular and Cellular Biology. 14: 3276-82. PMID 8164680 DOI: 10.1128/Mcb.14.5.3276  0.29
1994 Wisdon R, Verma IM. Transformation by Fos proteins requires a C-terminal transactivation domain. Molecular and Cellular Biology. 13: 7429-38. PMID 7504176 DOI: 10.1128/Mcb.13.12.7429  0.29
2006 Bottero V, Withoff S, Verma IM. NF-kappaB and the regulation of hematopoiesis. Cell Death and Differentiation. 13: 785-97. PMID 16528384 DOI: 10.1038/Sj.Cdd.4401888  0.289
1999 Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM. Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations Proceedings of the National Academy of Sciences of the United States of America. 96: 13920-13925. PMID 10570174 DOI: 10.1073/Pnas.96.24.13920  0.289
1997 Verma IM, Somia N. Gene therapy -- promises, problems and prospects. Nature. 389: 239-42. PMID 9305836 DOI: 10.1038/38410  0.288
1990 Ofir R, Dwarki VJ, Rashid D, Verma IM. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature. 348: 80-2. PMID 2122257 DOI: 10.1038/348080A0  0.288
2009 Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, Verma IM. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proceedings of the National Academy of Sciences of the United States of America. 106: 2629-34. PMID 19196987 DOI: 10.1073/Pnas.0812256106  0.288
1990 Ransone LJ, Visvader J, Wamsley P, Verma IM. Trans-dominant negative mutants of Fos and Jun. Proceedings of the National Academy of Sciences of the United States of America. 87: 3806-10. PMID 2111017 DOI: 10.1073/Pnas.87.10.3806  0.288
1994 Chiao PJ, Miyamoto S, Verma IM. Autoregulation of I kappa B alpha activity. Proceedings of the National Academy of Sciences of the United States of America. 91: 28-32. PMID 8278379 DOI: 10.1073/Pnas.91.1.28  0.287
2000 Verma IM. A tumultuous year for gene therapy Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 415-416. PMID 11082313 DOI: 10.1006/Mthe.2000.0213  0.287
2005 Blesch A, Conner J, Pfeifer A, Gasmi M, Ramirez A, Britton W, Alfa R, Verma I, Tuszynski MH. Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 916-25. PMID 15922962 DOI: 10.1016/J.Ymthe.2005.01.007  0.287
1989 Ransone LJ, Visvader J, Lamph WW, Sassone-Corsi P, Verma IM. fos and jun interaction: the role of the leucine zipper. International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement. 4: 10-21. PMID 2509385 DOI: 10.1002/Ijc.2910440705  0.287
1980 Jones M, Bosselman RA, van der Hoorn FA, Berns A, Fan H, Verma IM. Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells. Proceedings of the National Academy of Sciences of the United States of America. 77: 2651-5. PMID 6248858 DOI: 10.1073/Pnas.77.5.2651  0.286
1989 Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proceedings of the National Academy of Sciences of the United States of America. 86: 6077-81. PMID 2762315 DOI: 10.1073/Pnas.86.16.6077  0.285
2002 Li Q, Verma IM. NF-|[kappa]|B regulation in the immune system Nature Reviews Immunology. 2: 975-975. DOI: 10.1038/Nri968  0.285
2002 Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell. 1: 493-503. PMID 12124178 DOI: 10.1016/S1535-6108(02)00068-5  0.285
2016 Polley S, Passos DO, Huang DB, Mulero MC, Mazumder A, Biswas T, Verma IM, Lyumkis D, Ghosh G. Structural Basis for the Activation of IKK1/α. Cell Reports. 17: 1907-1914. PMID 27851956 DOI: 10.1016/J.Celrep.2016.10.067  0.285
1989 Ransone LJ, Visvader J, Sassone-Corsi P, Verma IM. Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins. Genes & Development. 3: 770-81. PMID 2501150 DOI: 10.1101/Gad.3.6.770  0.285
1989 Sassone-Corsi P, Der CJ, Verma IM. ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun. Molecular and Cellular Biology. 9: 3174-83. PMID 2507902 DOI: 10.1128/Mcb.9.8.3174  0.283
2000 Verma IM, Woo SLC. Modern Medicine, a Young Society, and a New Journal. Molecular Therapy. 1. PMID 10933919 DOI: 10.1006/Mthe.1999.0018  0.283
1979 Verma IM. Genome organization of retroviruses. III. Restriction endonuclease cleavage maps of mouse sarcoma virus double-stranded DNA synthesized in vitro. Nucleic Acids Research. 6: 1863-7. PMID 221890 DOI: 10.1093/Nar/6.5.1863  0.282
2001 Verma IM. Germline gene therapy: Yes or no? Molecular Therapy. 4: 1. PMID 11472097 DOI: 10.1006/Mthe.2001.0420  0.282
1997 Schwarz EM, Krimpenfort P, Berns A, Verma IM. Immunological defects in mice with a targeted disruption in Bcl-3. Genes & Development. 11: 187-97. PMID 9009202 DOI: 10.1101/Gad.11.2.187  0.281
1981 Van Beveren C, Goddard JG, Berns AJ, Verma IM. Biogenesis of a transforming gene. Molecular Biology Reports. 7: 163-5. PMID 7254205 DOI: 10.1007/Bf00778748  0.28
1979 Chien YH, Lai M, Shih TY, Verma IM, Scolnick EM, Roy-Burman P, Davidson N. Heteroduplex analysis of the sequence relationships between the genomes of Kirsten and Harvey sarcoma viruses, their respective parental murine leukemia viruses, and the rat endogenous 30S RNA Journal of Virology. 31: 752-760. PMID 229250 DOI: 10.1128/Jvi.31.3.752-760.1979  0.279
1996 Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB Science. 274: 787-789. PMID 8864120 DOI: 10.1126/Science.274.5288.787  0.278
2000 Verma IM, Gage FH. Genome and gene therapy Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 95. PMID 10947933 DOI: 10.1006/Mthe.2000.0109  0.278
1980 Berns AJ, Lai MH, Bosselman RA, McKennett MA, Bacheler LT, Fan H, Maandag EC, van der Putten HV, Verma IM. Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda. Journal of Virology. 36: 254-63. PMID 6255210 DOI: 10.1128/Jvi.36.1.254-263.1980  0.278
1996 Schwarz EM, Van Antwerp D, Verma IM. Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha. Molecular and Cellular Biology. 16: 3554-9. PMID 8668171 DOI: 10.1128/Mcb.16.7.3554  0.278
1980 Bosselman RA, Verma IM. Genome organization of retroviruses. V. In vitro-synthesized Moloney murine leukemia viral DNA has long terminal redundancy. Journal of Virology. 33: 487-93. PMID 6245245 DOI: 10.1128/Jvi.33.1.487-493.1980  0.278
2003 Kootstra NA, Münk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells Proceedings of the National Academy of Sciences of the United States of America. 100: 1298-1303. PMID 12547912 DOI: 10.1073/Pnas.0337541100  0.277
1999 Verma IM. Textbook of Gene Therapy Nature Medicine. 5: 371-371. DOI: 10.1038/7357  0.277
2001 Verma IM. Gene therapy and jurisprudence Molecular Therapy. 4: 393. PMID 11708873 DOI: 10.1006/Mthe.2001.0484  0.277
2000 Verma IM. Gene therapy: beyond 2000 Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 493. PMID 10933971 DOI: 10.1006/Mthe.2000.0084  0.277
1979 Chien YH, Verma IM, Duesberg PH, Davidson N. Heteroduplex analysis of the RNA of clone 3 Moloney murine sarcoma virus. Journal of Virology. 32: 1028-32. PMID 229257 DOI: 10.1128/Jvi.32.3.1028-1032.1979  0.275
1982 Van Beveren C, Rands E, Chattopadhyay SK, Lowy DR, Verma IM. Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site. Journal of Virology. 41: 542-556. DOI: 10.1128/Jvi.41.2.542-556.1982  0.275
1998 Blömer U, Kafri T, Randolph-Moore L, Verma IM, Gage FH. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death Proceedings of the National Academy of Sciences of the United States of America. 95: 2603-2608. PMID 9482933 DOI: 10.1073/Pnas.95.5.2603  0.274
2002 Verma IM. A gene therapy institute for NIH? Molecular Therapy. 5: 213. PMID 11863406 DOI: 10.1006/Mthe.2002.0552  0.274
2000 Somia N, Verma IM. Gene therapy: Trials and tribulations Nature Reviews Genetics. 1: 91-99. PMID 11253666 DOI: 10.1038/35038533  0.274
2007 Liu AC, Welsh DK, Ko CH, Tran HG, Zhang EE, Priest AA, Buhr ED, Singer O, Meeker K, Verma IM, Doyle FJ, Takahashi JS, Kay SA. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell. 129: 605-16. PMID 17482552 DOI: 10.1016/J.Cell.2007.02.047  0.274
2000 Somia NV, Miyoshi H, Schmitt MJ, Verma IM. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. Journal of Virology. 74: 4420-4. PMID 10756057 DOI: 10.1128/Jvi.74.9.4420-4424.2000  0.273
2015 Hurtado de Mendoza T, Liu F, Verma IM. Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response. Plos One. 10: e0142161. PMID 26565411 DOI: 10.1371/Journal.Pone.0142161  0.272
2001 Verma IM. Stem cell research: Win, win, win by keeping politics out Molecular Therapy. 3: 641. PMID 11356067 DOI: 10.1006/Mthe.2001.0339  0.271
1978 Chien YH, Verma IM, Shih TY, Scolnick EM, Davidson N. Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses. Journal of Virology. 28: 352-360. DOI: 10.1128/Jvi.28.1.352-360.1978  0.27
2006 Liao W, Nguyen MT, Imamura T, Singer O, Verma IM, Olefsky JM. Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes. Endocrinology. 147: 2245-52. PMID 16497797 DOI: 10.1210/En.2005-1638  0.27
2000 Verma IM. Gene therapy: the need for basic science Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 531. PMID 11124051 DOI: 10.1006/Mthe.2000.0220  0.269
2007 Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America. 104: 7594-9. PMID 17463083 DOI: 10.1073/Pnas.0702170104  0.268
1991 Ransone LJ, Verma IM. Nuclear proto-oncogenes fos and jun. Annual Review of Cell Biology. 6: 539-57. PMID 2125830 DOI: 10.1146/Annurev.Cb.06.110190.002543  0.268
2003 Gage FH, Verma IM. Stem cells at the dawn of the 21st century. Proceedings of the National Academy of Sciences of the United States of America. 100: 11817-8. PMID 12915737 DOI: 10.1073/Pnas.1834433100  0.268
2007 Bissig KD, Le TT, Woods NB, Verma IM. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proceedings of the National Academy of Sciences of the United States of America. 104: 20507-11. PMID 18077355 DOI: 10.1073/Pnas.0710528105  0.267
1995 Verma IM. Just an appetizer Chemistry & Biology. 2: 719. DOI: 10.1016/1074-5521(95)90099-3  0.266
1980 Van Beveren C, Goddard JG, Berns A, Verma IM. Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences. Proceedings of the National Academy of Sciences of the United States of America. 77: 3307-11. PMID 6251455 DOI: 10.1073/Pnas.77.6.3307  0.266
2011 Bossard C, Friedmann-Morvinski D, Soria C, Espantman K, Chalkley R, Verma I, Burlingame A, O'Shea C. Abstract 4061: TRIM-NHL proteins: New potential targets for cancer therapy Cellular and Molecular Biology. 71: 4061-4061. DOI: 10.1158/1538-7445.Am2011-4061  0.266
2011 Padler-Karavani V, Hurtado-Ziola N, Pu M, Yu H, Huang S, Muthana S, Chokhawala HA, Cao H, Secrest P, Friedmann-Morvinski D, Singer O, Ghaderi D, Verma IM, Liu YT, Messer K, et al. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Research. 71: 3352-63. PMID 21505105 DOI: 10.1158/0008-5472.Can-10-4102  0.265
2014 Verma IM, Nusinovich Y. Science Translational Medicine Podcast: 19 November 2014 Science Translational Medicine. 6: 263pc6-263pc6. DOI: 10.1126/Scitranslmed.Aaa1988  0.264
1984 Müller R, Verma IM. Expression of cellular oncogenes. Current Topics in Microbiology and Immunology. 112: 73-115. PMID 6383726 DOI: 10.1007/978-3-642-69677-0_4  0.262
2010 Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. The Journal of Clinical Investigation. 120: 924-30. PMID 20179355 DOI: 10.1172/Jci40094  0.262
2011 Hurtado de Mendoza T, Balana B, Slesinger PA, Verma IM. Organotypic cerebellar cultures: apoptotic challenges and detection. Journal of Visualized Experiments : Jove. PMID 21633327 DOI: 10.3791/2564  0.262
2003 Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, Ohno A, Verma IM, Vale W. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology (Baltimore, Md.). 38: 1107-15. PMID 14578849 DOI: 10.1053/Jhep.2003.50483  0.262
1983 ADAMSON E, MULLER R, VERMA I. Expression of c- genes c- and c- in developing mouse tissues Cell Biology International Reports. 7: 557-558. DOI: 10.1016/0309-1651(83)90176-5  0.262
1996 Van Antwerp DJ, Verma IM. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Molecular and Cellular Biology. 16: 6037-45. PMID 8887633 DOI: 10.1128/Mcb.16.11.6037  0.261
2005 Galimi F, Summers RG, van Praag H, Verma IM, Gage FH. A role for bone marrow-derived cells in the vasculature of noninjured CNS. Blood. 105: 2400-2. PMID 15572598 DOI: 10.1182/Blood-2004-02-0612  0.26
1994 Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America. 91: 12740-4. PMID 7809113 DOI: 10.1073/Pnas.91.26.12740  0.26
2007 El-Amouri SS, Zhu H, Yu J, Gage FH, Verma IM, Kindy MS. Neprilysin protects neurons against Abeta peptide toxicity. Brain Research. 1152: 191-200. PMID 17459354 DOI: 10.1016/J.Brainres.2007.03.072  0.26
2011 Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 108: 17450-5. PMID 21969599 DOI: 10.1073/Pnas.1114518108  0.259
2013 Soda Y, Myskiw C, Rommel A, Verma IM. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. Journal of Molecular Medicine (Berlin, Germany). 91: 439-48. PMID 23512266 DOI: 10.1007/S00109-013-1019-Z  0.259
1987 Verma IM, Sassone-Corsi P. Proto-oncogene fos: complex but versatile regulation. Cell. 51: 513-4. PMID 3119222 DOI: 10.1016/0092-8674(87)90115-2  0.259
2004 Verma IM. Doping, gene transfer and sport. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 405. PMID 15336640 DOI: 10.1016/J.Ymthe.2004.08.004  0.257
2014 Lee HS, Ghetti A, Pinto-Duarte A, Wang X, Dziewczapolski G, Galimi F, Huitron-Resendiz S, Piña-Crespo JC, Roberts AJ, Verma IM, Sejnowski TJ, Heinemann SF. Astrocytes contribute to gamma oscillations and recognition memory. Proceedings of the National Academy of Sciences of the United States of America. 111: E3343-52. PMID 25071179 DOI: 10.1073/Pnas.1410893111  0.257
1995 Barroga CF, Stevenson JK, Schwarz EM, Verma IM. Constitutive phosphorylation of I kappa B alpha by casein kinase II. Proceedings of the National Academy of Sciences of the United States of America. 92: 7637-41. PMID 7644469 DOI: 10.1073/Pnas.92.17.7637  0.255
1985 Deschamps J, Mitchell RL, Meijlink F, Kruijer W, Schubert D, Verma IM. Proto-oncogene fos is expressed during development, differentiation, and growth. Cold Spring Harbor Symposia On Quantitative Biology. 50: 733-45. PMID 3868506 DOI: 10.1101/Sqb.1985.050.01.091  0.253
2012 Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma IM, Kosik KS. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 31: 1884-95. PMID 21874051 DOI: 10.1038/Onc.2011.380  0.253
2003 Kanazawa Y, Verma IM. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver Proceedings of the National Academy of Sciences of the United States of America. 100: 11850-11853. PMID 12920184 DOI: 10.1073/Pnas.1834198100  0.252
2015 Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma IM, et al. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell. 162: 766-79. PMID 26276631 DOI: 10.1016/J.Cell.2015.07.026  0.251
1975 Gibson W, Verma IM. Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses. Proceedings of the National Academy of Sciences of the United States of America. 71: 4991-4. PMID 4140514 DOI: 10.1073/Pnas.71.12.4991  0.25
2014 Khanna A, Firth A, Verma IM. Disease In A Dish Model Of Cystic Fibrosis From Inducible Pluripotent Stem Cells Derived From Skin Fibroblasts Journal of Surgical Research. 186: 523. DOI: 10.1016/J.Jss.2013.11.370  0.249
1988 De Togni P, Niman H, Raymond V, Sawchenko P, Verma IM. Detection of fos protein during osteogenesis by monoclonal antibodies. Molecular and Cellular Biology. 8: 2251-6. PMID 3133556 DOI: 10.1128/Mcb.8.5.2251  0.249
2001 Verma IM. Ombudsman or hotline for gene therapy clinical trials? Molecular Therapy. 3: 817-818. PMID 11407893 DOI: 10.1006/Mthe.2001.0348  0.248
2007 Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T, Verma IM, Olefsky JM. Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism. 293: E219-27. PMID 17389706 DOI: 10.1152/Ajpendo.00695.2006  0.245
2000 Verma IM. Gene therapy: public education Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 177. PMID 10985946 DOI: 10.1006/Mthe.2000.0127  0.244
2014 Khanna A, Menon T, Firth A, Verma I. Skin Fibroblast Derived Inducible Pluripotent Stem Cells To Develop Disease In A Dish Model Of Alport's Disease Journal of Surgical Research. 186: 646. DOI: 10.1016/J.Jss.2013.11.675  0.243
2001 Verma IM. Are the benefits of stem cells being oversold? Molecular Therapy. 4: 161. PMID 11545604 DOI: 10.1006/Mthe.2001.0451  0.243
2009 Saberi M, Woods NB, de Luca C, Schenk S, Lu JC, Bandyopadhyay G, Verma IM, Olefsky JM. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metabolism. 10: 419-29. PMID 19883619 DOI: 10.1016/J.Cmet.2009.09.006  0.241
1993 Dwarki VJ, Malone RW, Verma IM. Cationic liposome-mediated RNA transfection. Methods in Enzymology. 217: 644-54. PMID 7682647 DOI: 10.1016/0076-6879(93)17093-K  0.24
1990 Ransone LJ, Verma IM. Association of nuclear oncoproteins fos and jun. Current Opinion in Cell Biology. 1: 536-40. PMID 2516738 DOI: 10.1016/0955-0674(89)90017-3  0.239
2018 Mazor R, Friedmann-Morvinski D, Alsaigh T, Kleifeld O, Kistler EB, Rousso-Noori L, Huang C, Li JB, Verma IM, Schmid-Schönbein GW. Cleavage of the leptin receptor by matrix metalloproteinase-2 promotes leptin resistance and obesity in mice. Science Translational Medicine. 10. PMID 30135249 DOI: 10.1126/Scitranslmed.Aah6324  0.239
1978 Verma IM, McKennett MA. Genome organization of RNA tumor viruses II. Physical maps of in vitro-synthesized Moloney murine leukemia virus double-stranded DNA by restriction endonucleases. Journal of Virology. 26: 630-645. DOI: 10.1128/Jvi.26.3.630-645.1978  0.239
1995 Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes & Development. 9: 2723-35. PMID 7590248 DOI: 10.1101/Gad.9.22.2723  0.239
1979 Verma IM, Roberts CA, McKennett M, Green BE, Chien Y, Davidson N. Genome Organization Of Retroviruses Iv. Physical Mapping Of Murine Sarcoma Virus And Heteroduplex Analysis Of Recombinant Murine Leukemia Viruses Cell Biology and Immunology of Leukocyte Function. 829-848. DOI: 10.1016/B978-0-12-569650-0.50108-X  0.239
2004 Verma IM. Stem cell politics get dirty. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 633. PMID 15143773 DOI: 10.1016/J.Ymthe.2004.04.001  0.236
2014 Natarajan S, Thanasupawat T, Rommel A, Bergen H, Verma I, Bigio MD, Pitz M, Hasinoff BB, Krcek J, Hombach-Klonisch S, Klonisch T. Targeting oncofetal high mobility group A2 (HMGA2) to increase sensitivity to temozolomide (TMZ) in glioblastoma (GB) cells Canadian Journal of Neurological Sciences. 41. DOI: 10.1017/Cjn.2014.52  0.233
1990 Valerio D, Einerhand MP, Wamsley PM, Bakx TA, Li CL, Verma IM. Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat. Gene. 84: 419-27. PMID 2612913 DOI: 10.1016/0378-1119(89)90516-7  0.231
2016 Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation. Oncotarget. PMID 26859681 DOI: 10.18632/Oncotarget.7232  0.229
2018 Seale N, Ramaswamy S, Shih YR, Verma I, Varghese S. Macroporous dual compartment hydrogels for minimally invasive transplantation of primary human hepatocytes. Transplantation. PMID 29916986 DOI: 10.1097/Tp.0000000000002330  0.226
2003 Verma IM. The DNA helix at 50 Molecular Therapy. 7: 427. PMID 12731541 DOI: 10.1016/S1525-0016(03)00075-3  0.222
2002 Verma IM. The Common Thread: A Story of Science, Politics, Ethics and the Human Genome Nature Medicine. 8: 1345-1345. DOI: 10.1038/Nm1202-1345  0.222
2004 Verma IM. Agbiotech: success depends on trust. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 1. PMID 15233936 DOI: 10.1016/J.Ymthe.2004.06.023  0.221
2014 Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E. Erratum: Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma (Proc Natl Acad Sci USA (2011) 108 (17450-17455) DOI: 10.1073/pnas.1114518108) Proceedings of the National Academy of Sciences of the United States of America. 111. DOI: 10.1073/Pnas.1413457111  0.218
2002 Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood. 100: 2732-6. PMID 12351379 DOI: 10.1182/blood-2002-04-1245  0.217
1991 Atwater JA, Wisdom R, Verma IM. Regulated mRNA stability. Annual Review of Genetics. 24: 519-41. PMID 2088178 DOI: 10.1146/Annurev.Ge.24.120190.002511  0.216
1994 Stevens CF, Verma I. Memory. A model with good CREdentials. Current Biology : Cb. 4: 736-8. PMID 7953565 DOI: 10.1016/S0960-9822(00)00164-0  0.216
1986 Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus Nature. 320: 277-280. PMID 2421165 DOI: 10.1038/320277A0  0.215
2018 McNutt MK, Bradford M, Drazen JM, Hanson B, Howard B, Jamieson KH, Kiermer V, Marcus E, Pope BK, Schekman R, Swaminathan S, Stang PJ, Verma IM. Transparency in authors' contributions and responsibilities to promote integrity in scientific publication. Proceedings of the National Academy of Sciences of the United States of America. PMID 29487213 DOI: 10.1073/Pnas.1715374115  0.215
1977 Verma IM. The reverse transcriptase. Biochimica Et Biophysica Acta. 473: 1-38. PMID 66065 DOI: 10.1016/0304-419X(77)90005-1  0.213
1982 Bosselman RA, van Straaten F, Van Beveren C, Verma IM, Vogt M. Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA. Journal of Virology. 44: 19-31. DOI: 10.1128/jvi.44.1.19-31.1982  0.213
2007 Pulivarthy SR, Tanaka N, Welsh DK, De Haro L, Verma IM, Panda S. Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proceedings of the National Academy of Sciences of the United States of America. 104: 20356-61. PMID 18077393 DOI: 10.1073/Pnas.0708877104  0.213
2004 Verma IM. The NIH roadmap Molecular Therapy. 9: 1. DOI: 10.1016/J.Ymthe.2004.11.048  0.212
1984 Cochran BH, Zullo J, Verma IM, Stiles CD. Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor. Science (New York, N.Y.). 226: 1080-2. PMID 6093261 DOI: 10.1126/Science.6093261  0.211
2003 Kanazawa Y, Verma IM. 269 Failure of bone marrow derived cells to replace injured livers Hepatology. 38: 286-286. DOI: 10.1016/S0270-9139(03)80312-9  0.209
1987 Verma IM. AIDS: Modern concepts and therapeutic challenges Cell. 48: 911. DOI: 10.1016/0092-8674(87)90698-2  0.209
2013 Verma IM, Verman IM, Harris DJ. PNAS introduces new magazine section. Proceedings of the National Academy of Sciences of the United States of America. 110: 2427. PMID 23365137 DOI: 10.1073/Pnas.1300186110  0.207
2014 Verma IM. Editorial expression of concern: Experimental evidence of massive-scale emotional contagion through social networks. Proceedings of the National Academy of Sciences of the United States of America. 111: 10779. PMID 24994898 DOI: 10.1073/Pnas.1412469111  0.206
2014 Verma IM. Simplifying the Direct Submission process. Proceedings of the National Academy of Sciences of the United States of America. 111: 14311. PMID 25246596 DOI: 10.1073/Pnas.1417688111  0.205
2001 Steele FR, Verma IM. Molecular therapy's first year Molecular Therapy. 3: 1. DOI: 10.1006/Mthe.2000.0247  0.205
2008 Tiscornia G, Singer O, Verma IM. Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version A. Csh Protocols. 2008: pdb.prot5009. PMID 21356884 DOI: 10.1101/pdb.prot5009  0.204
2012 Verma IM. PNAS Plus: Refining a successful experiment. Proceedings of the National Academy of Sciences of the United States of America. 109: 13469. PMID 22872861 DOI: 10.1073/Pnas.1212313109  0.203
2002 Verma IM. New editor of Molecular Therapy Molecular Therapy. 6: 300. DOI: 10.1006/Mthe.2002.0685  0.202
2017 Verma IM. Preprint servers facilitate scientific discourse. Proceedings of the National Academy of Sciences of the United States of America. PMID 29078419 DOI: 10.1073/Pnas.1716857114  0.202
2016 Verma IM. PNAS at 101: Heading into the next century. Proceedings of the National Academy of Sciences of the United States of America. PMID 26933217 DOI: 10.1073/Pnas.1602165113  0.202
2000 Li Q, Estepa G, Memet S, Israel A, Verma IM. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation Genes and Development. 14: 1729-1733. PMID 10898787  0.202
1984 Verma IM. From c-fos to v-fos. Nature. 308: 317. PMID 6709039 DOI: 10.1038/308317A0  0.202
2016 Polley S, Passos DO, Huang DB, Mulero MC, Mazumder A, Biswas T, Verma IM, Lyumkis D, Ghosh G. Structural Basis for the Activation of IKK1/ alpha. Cell Reports. 17: 1907-1914. DOI: 10.2210/Pdb5Ebz/Pdb  0.199
2015 Verma IM. Impact, not impact factor. Proceedings of the National Academy of Sciences of the United States of America. 112: 7875-6. PMID 26080449 DOI: 10.1073/Pnas.1509912112  0.198
2014 Verma IM. Happy 100th birthday, PNAS Proceedings of the National Academy of Sciences of the United States of America. 111: 5757. DOI: 10.1073/Pnas.1405552111  0.197
2014 Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman EP, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Erratum: Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis (The Journal of Clinical Investigation (2013) 123:1 (405-417) (DOI: 10.1172/JCI63811) Journal of Clinical Investigation. 124. DOI: 10.1172/Jci77927  0.195
2002 Verma IM. Biopiracy: Distrust widens the rich-poor divide Molecular Therapy. 5: 95. PMID 11829514 DOI: 10.1006/Mthe.2002.0534  0.195
1980 Sutcliffe JG, Shinnick TM, Verma IM, Lerner RA. Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene. Proceedings of the National Academy of Sciences of the United States of America. 77: 3302-6. PMID 6251454 DOI: 10.1073/Pnas.77.6.3302  0.192
2016 Verma IM. Celebrating our 20th digital anniversary. Proceedings of the National Academy of Sciences of the United States of America. PMID 27999178 DOI: 10.1073/Pnas.1619741114  0.192
2005 Dhawan J, Gokhale RS, Verma IM. Bioscience in India: times are changing. Cell. 123: 743-5. PMID 16325565 DOI: 10.1016/J.Cell.2005.11.018  0.192
2005 Spencer BJ, Verma IM. 428. A Novel Approach for the Treatment of the Neurological Symptoms of MPS VII (Sly Disease) Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.430  0.192
2002 Verma IM. Making the promise a reality Molecular Therapy. 6: 695. PMID 12498763 DOI: 10.1006/Mthe.2002.0818  0.191
2004 Verma IM. Visa crisis hurts U.S. science. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 767. PMID 15194044 DOI: 10.1016/J.Ymthe.2004.05.009  0.191
2018 Subramaniam S, Caldwell A, Bhargava V, Friedman-Morvinski D, Lu Q, Yuan S, Galasko D, Verma I, Wagner S. Mechanisms Defining the Neuronal State Space Biophysical Journal. 114: 23a-24a. DOI: 10.1016/J.Bpj.2017.11.172  0.189
2004 Verma IM. AIDS: No end in sight Molecular Therapy. 9: 141. PMID 14971375 DOI: 10.1016/J.Ymthe.2004.01.002  0.189
2002 Verma IM. Success and setback: Another adverse event Molecular Therapy. 6: 565-566. PMID 12409253 DOI: 10.1006/Mthe.2002.0709  0.186
2001 Verma IM. Adverse event reporting: Essential for science and public trust Molecular Therapy. 4: 83. PMID 11482977 DOI: 10.1006/Mthe.2001.0436  0.186
2002 Kessler TA, Pfeifer A, Silletti S, Mesters RM, Berdel WE, Verma I, Cheresh D. Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies Annals of Hematology. 81: S69-S70. PMID 12611083  0.185
1999 Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM. A Packaging Cell Line for Lentivirus Vectors Journal of Virology. 73: 576-584. DOI: 10.1128/jvi.73.1.576-584.1999  0.185
2002 Verma I. 2002 Nobel prize for physiology and medicine Molecular Therapy. 6: 698. PMID 12498764 DOI: 10.1006/Mthe.2002.0824  0.184
2003 Verma IM. SARS: Fear of global pandemic Molecular Therapy. 7: 711. PMID 12788644 DOI: 10.1016/S1525-0016(03)00158-8  0.183
2014 Friedmann-Morvinski D, Verma IM. Dedifferentiation and reprogramming: origins of cancer stem cells. Embo Reports. 15: 244-53. PMID 24531722 DOI: 10.1002/embr.201338254  0.181
2001 Verma IM. Pharma + profits = Continued AIDS epidemic Molecular Therapy. 3: 419. PMID 11319899 DOI: 10.1006/Mthe.2001.0309  0.181
2000 Pando MP, Verma IM. Signal-dependent and -independent degradation of free and NF-κb-bound IκBα Journal of Biological Chemistry. 275: 21278-21286. PMID 10801847 DOI: 10.1074/jbc.M002532200  0.18
1990 Ivashkiv LB, Liou HC, Kara CJ, Lamph WW, Verma IM, Glimcher LH. mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Molecular and Cellular Biology. 10: 1609-21. PMID 2138707 DOI: 10.1128/Mcb.10.4.1609  0.18
2003 Verma IM. 2003: We have to do better Molecular Therapy. 7: 1. DOI: 10.1016/S1525-0016(02)00043-6  0.18
2002 Verma IM. Politics and AIDS: A bad mix Molecular Therapy. 5: 485. PMID 11991737 DOI: 10.1006/Mthe.2002.0592  0.179
2000 Verma IM. AIDS: are we doing enough? Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 299. PMID 11020343 DOI: 10.1006/Mthe.2000.0188  0.178
2002 Verma IM. Looking back, looking ahead Molecular Therapy. 5: 1. DOI: 10.1006/Mthe.2001.0506  0.178
2002 Verma IM. Politics and scientific publishing: Noli Me Tangere Molecular Therapy. 6: 431-435. PMID 12377181 DOI: 10.1006/Mthe.2002.0688  0.177
2004 Verma IM. The long path to a career in science Molecular Therapy. 9: 311. DOI: 10.1016/J.Ymthe.2004.02.001  0.177
2001 Verma IM. Bioterrorism: Fear and reality Molecular Therapy. 4: 509. DOI: 10.1006/Mthe.2001.0487  0.176
2002 Verma IM. Hypothesis-driven science Molecular Therapy. 6: 1. PMID 12095295 DOI: 10.1006/Mthe.2002.0622  0.176
2001 Verma IM. An unfathomable tragedy Molecular Therapy. 4: 281. DOI: 10.1006/Mthe.2001.0471  0.176
2003 Verma IM. Illiteracy, ignorance, intolerance=terrorism Molecular Therapy. 8: 1. PMID 12872760 DOI: 10.1016/S1525-0016(03)00187-4  0.176
2015 Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM, Ke E, Dargitz CT, Wright R, Khanna A, Gage FH, Verma IM. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs. Cell Reports. 12: 1385-90. PMID 26299960 DOI: 10.1016/J.Celrep.2015.07.062  0.176
2003 Verma IM. Triumph and tragedy in space Molecular Therapy. 7: 289. DOI: 10.1016/S1525-0016(03)00050-9  0.174
2004 Verma IM. Musings for young scientists. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 201. PMID 15294164 DOI: 10.1016/J.Ymthe.2004.07.008  0.174
2003 Verma IM. Contradictions and extremes Molecular Therapy. 8: 863. DOI: 10.1016/J.Ymthe.2003.10.007  0.173
2002 Verma IM. Meetings, meetings, and more meetings Molecular Therapy. 6: 299. DOI: 10.1006/Mthe.2002.0667  0.173
2004 Verma IM. Open Access to Scientific Publications Molecular Therapy. 10: 609. DOI: 10.1016/J.Ymthe.2004.09.001  0.172
2004 Verma IM. Francis Crick: A Personal Memory Molecular Therapy. 10: 613. DOI: 10.1016/J.Ymthe.2004.09.004  0.171
2003 Verma IM. Good-bye Dolly Molecular Therapy. 7: 565. PMID 12755157 DOI: 10.1016/S1525-0016(03)00109-6  0.171
2004 Verma IM. Thanks, Adieu and Farewell Molecular Therapy. 10: 973. DOI: 10.1016/J.Ymthe.2004.11.003  0.171
2002 Verma IM. Censorship of scientific publications: A bad idea Molecular Therapy. 5: 337. PMID 11945057 DOI: 10.1006/Mthe.2002.0569  0.169
2003 Verma IM. Fraud and deception in science Molecular Therapy. 8: 519. PMID 14565217 DOI: 10.1016/J.Ymthe.2003.08.006  0.167
1993 Polak M, Scharfmann R, Seilheimer B, Eisenbarth G, Dressler D, Verma IM, Potter H. Nerve growth factor induces neuron-like differentiation of an insulin- secreting pancreatic beta cell line Proceedings of the National Academy of Sciences of the United States of America. 90: 5781-5785. PMID 8516328 DOI: 10.1073/Pnas.90.12.5781  0.164
2013 Hu YS, Zhu Q, Elkins K, Tse K, Li Y, Fitzpatrick JA, Verma IM, Cang H. Light-sheet Bayesian microscopy enables deep-cell super-resolution imaging of heterochromatin in live human embryonic stem cells. Optical Nanoscopy. 2. PMID 27795878 DOI: 10.1186/2192-2853-2-7  0.164
2001 Verma IM. New rules of publication: Changing mores Molecular Therapy. 3: 277. DOI: 10.1006/Mthe.2001.0281  0.164
2015 Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM, Ke E, Dargitz CT, Wright R, Khanna A, Gage FH, Verma IM. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs Cell Reports. 12: 1385-1390. DOI: 10.1016/j.celrep.2015.07.062  0.16
1990 Verma IM, Ransone LJ, Visvader J, Sassone-Corsi P, Lamph WW. fos-jun conspiracy: implications for the cell. Ciba Foundation Symposium. 150: 128-37; discussion 1. PMID 2115424 DOI: 10.1002/9780470513927.ch9  0.158
2012 Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science (New York, N.Y.). 338: 1080-4. PMID 23087000 DOI: 10.1126/Science.1226929  0.157
2017 Gopinath C, Chodisetty S, Verma IM, Nelson EJR. Efficiency of ubiquitous chromatin opening elements in driving the expression of human CD18 within self-inactivating lentiviral vectors for gene therapy applications Canadian Journal of Biotechnology. 1: 173-173. DOI: 10.24870/cjb.2017-a159  0.154
1979 Bosselman RA, Van Griensven LJ, Vogt M, Verma IM. Genome organization of retroviruses. VI. Heteroduplex analysis of ecotropic and xenotropic sequences of moloney mink cell focus-inducing viral RNA obtained from either a cloned isolate or a thymoma cell line. Journal of Virology. 32: 968-978. DOI: 10.1128/jvi.32.3.968-978.1979  0.154
2001 Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, Gaynor RB. Regulation of β-Catenin Function by the IκB Kinases Journal of Biological Chemistry. 276: 42276-42286. PMID 11527961 DOI: 10.1074/jbc.M104227200  0.152
2004 Verma IM. Nuclear factor (NF)-kappaB proteins: therapeutic targets. Annals of the Rheumatic Diseases. 63: ii57-ii61. PMID 15479873 DOI: 10.1136/ard.2004.028266  0.15
1978 Verma IM. Genome organization of RNA tumor viruses. I. In vitro synthesis of full-genome-length single-stranded and double-stranded viral DNA transcripts. Journal of Virology. 26: 615-629. DOI: 10.1128/jvi.26.3.615-629.1978  0.143
1982 Curran T, Peters G, Van Beveren C, Teich NM, Verma IM. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. Journal of Virology. 44: 674-682. DOI: 10.1128/jvi.44.2.674-682.1982  0.139
1987 Barber JR, Verma IM. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum Molecular and Cellular Biology. 7: 2201-2211. PMID 3110603 DOI: 10.1128/MCB.7.6.2201  0.136
1995 Verma IM. Gene therapy Hopes, hypes, and hurdles Interdisciplinary Science Reviews. 20: 96-98. DOI: 10.1179/isr.1995.20.4.96  0.135
1994 Verma IM. Gene Therapy: Hopes, Hypes, and Hurdles Molecular Medicine. 1: 2-3. DOI: 10.1007/bf03403525  0.135
1976 Verma IM, Varmus HE, Hunter E. Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells. Virology. 74: 16-29. PMID 62445 DOI: 10.1016/0042-6822(76)90124-0  0.134
1975 Verma IM. Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H. Journal of Virology. 15: 843-854. DOI: 10.1128/jvi.15.4.843-854.1975  0.133
1991 Verma IM. Gene therapy. Scientific American. 263: 68-72, 81-4. PMID 2255890 DOI: 10.1038/scientificamerican1190-68  0.133
1975 Verma IM. Studies on reverse transcriptase of RNA tumor viruses. I. Localization of thermolabile DNA polymerase and RNase H activities on one polypeptide. Journal of Virology. 15: 121-126. DOI: 10.1128/jvi.15.1.121-126.1975  0.127
1980 Bosselman RA, Verma IM. Genome Organization of Retroviruses V. In Vitro-Synthesized Moloney Murine Leukemia Viral DNA Has Long Terminal Redundancy Journal of Virology. 33: 487-493. DOI: 10.1128/jvi.33.1.487-493.1980  0.126
1978 Lai MH, Verma IM. Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity. Journal of Virology. 25: 652-663. DOI: 10.1128/jvi.25.2.652-663.1978  0.121
2005 Verma I. Then and now Nature. 436: 478-479. PMID 16049468 DOI: 10.1038/436478a  0.12
1980 Sutcliffe JG, Shinnick TM, Lerner RA, Johnson P, Verma IM. Nucleotide sequence of a cloned murine leukemia virus DNA fragment. Cold Spring Harbor Symposia On Quantitative Biology. 44: 1275-9. PMID 6159135 DOI: 10.1101/Sqb.1980.044.01.139  0.119
2007 Kankkonen H, Vähäkangas E, Pakkanen T, Laurema A, Kholova I, Hedman M, Marr M, Verma I, Ylä-Herttuala S. LB-PO-854 LONG-TERM SAFETY STUDY OF LIVER-DIRECTED IN VIVO GENE TRANSFER WITH MOLONEY MURINE RETROVIRUSES AND LENTIVIRUSES IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS Atherosclerosis Supplements. 8: 229. DOI: 10.1016/S1567-5688(07)71870-6  0.113
1984 Barker PE, Rabin M, Watson M, Breg WR, Ruddle FH, Verma IM. Human c-fos oncogene mapped within chromosomal region 14q21----q31. Proceedings of the National Academy of Sciences of the United States of America. 81: 5826-30. PMID 6091112 DOI: 10.1073/pnas.81.18.5826  0.11
1998 Verma IM. "Green light" for gene transfer. Nature Biotechnology. 14: 576. PMID 9630941 DOI: 10.1038/nbt0596-576  0.108
1979 Chien YH, Verma IM, Duesberg PH, Davidson N. Heteroduplex analysis of the RNA of clone 3 Moloney murine sarcoma virus. Journal of Virology. 32: 1028-1032. DOI: 10.1128/jvi.32.3.1028-1032.1979  0.104
1973 Berns AJ, Bloemendal H, Kaufman SJ, Verma IM. Synthesis of DNA complementary to 14S calf lens crystallin messenger RNA by reverse transcriptase. Biochemical and Biophysical Research Communications. 52: 1013-9. PMID 4122882 DOI: 10.1016/0006-291X(73)91038-3  0.102
1978 Lai MH, Verma IM, Tronick SR, Aaronson SA. Mammalian retrovirus-associated RNase H is virus coded. Journal of Virology. 27: 823-825. DOI: 10.1128/Jvi.27.3.823-825.1978  0.101
1987 Verma IM, Graham WR. The fos oncogene. Advances in Cancer Research. 49: 29-52. PMID 2823543 DOI: 10.1016/S0065-230X(08)60793-9  0.096
1975 Tronick SR, Stephenson JR, Verma IM, Aaronson SA. Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions. Journal of Virology. 16: 1476-1482. DOI: 10.1128/jvi.16.6.1476-1482.1975  0.096
1979 Chien Y, Lai M, Shih TY, Verma IM, Scolnick EM, Roy-Burman P, Davidson N. Heteroduplex Analysis of the Sequence Relationships Between the Genomes of Kirsten and Harvey Sarcoma Viruses, Their Respective Parental Murine Leukemia Viruses, and the Rat Endogenous 30S RNA Journal of Virology. 31: 752-760. DOI: 10.1128/jvi.31.3.752-760.1979  0.095
2013 Hu YS, Zhu Q, Fitzpatrick J, Verma IM, Cang H. Imaging heterochromatin in human embryonic stem cells with light-sheet Bayesian microscopy Epigenetics & Chromatin. 6: P109. DOI: 10.1186/1756-8935-6-S1-P109  0.092
2013 Hu YS, Zhu Q, Elkins K, Tse K, Li Y, Fitzpatrick JAJ, Verma IM, Cang H. Light-sheet Bayesian microscopy enables deepcell super-resolution imaging of heterochromatin in live human embryonic stem cells Optical Nanoscopy. 2: 1-12. DOI: 10.1186/2192-2853-2-7  0.091
1978 Fan H, Verma IM. Size analysis and relationship of murine leukemia virus-specific mRNA's: evidence for transposition of sequences during synthesis and processing of subgenomic mRNA. Journal of Virology. 26: 468-478. DOI: 10.1128/jvi.26.2.468-478.1978  0.082
1993 Nabel GJ, Verma IM. Proposed NF-kappa B/I kappa B family nomenclature. Genes & Development. 7: 2063. PMID 8224837 DOI: 10.1101/Gad.7.11.2063  0.082
2015 Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma IM, et al. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer Cell. 162: 766-779. DOI: 10.1016/j.cell.2015.07.026  0.077
1980 Bosselman RA, Van Griensven LJ, Vogt M, Verma IM. Genome organization of retroviruses IX. Analysis of the genomes of Friend spleen focus-forming (F-SFFV) and helper murine leukemia viruses by heteroduplex-formation. Virology. 102: 234-9. PMID 6245506 DOI: 10.1016/0042-6822(80)90088-4  0.075
2005 Singer O, Tiscornia G, Verma I. siRNA delivery by lentiviral vectors: Design and applications Rna Interference Technology: From Basic Science to Drug Development. 174-185. DOI: 10.1017/CBO9780511546402.015  0.074
1986 Verma I. Proto-oncogenes: Role in development, growth and differentiation Leukemia Research. 10: 931. DOI: 10.1016/0145-2126(86)90325-5  0.073
Hide low-probability matches.